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Bacterial microcompartments (BMCs) likely represent the largest protein complex 
found in bacterial cells (estimated 18,000 subunits). BMCs are associated with 
specific metabolic processes such as carbon fixation in the case of carboxysomes or 
carbon utilisation in the case of the 1,2-propanediol utilisation metabolosome. With 
all BMCs there is still much to learn about the structure and function of these 
supramolecular assemblies. 
In this project the structure and function of the Pdu BMC has been studied through a 
combination of recombinant DNA technology, proteomics, fluorescence microscopy, 
transmission electron microscopy (TEM) and atomic force microscopy (AFM). Initially, 
wild type Citrobacter freundii (C. freundii) Pdu BMCs were compared to recombinant 
BMCs that had been produced in Escherichia coli (E. coli). These were found to have 
very similar profiles in terms of BMC shell composition, size (120-130 nm on average) 
and shape. However, recombinant empty BMCs (eBMCs), generated by the 
coexpression of the genes for just the shell proteins, were found to be distinctly 
different in that they incorporated more of the first shell protein of the operon, PduA, 
and were also significantly smaller (55-80 nm on average) than the complete BMCs. 
This work provides the first recorded application of AFM for the study of BMCs and 
revealed that the eBMCs were stiffer and less flexible than complete BMCs and it is 
unclear if differences in shell protein composition or the lack of the internal scaffold 
is causing the reported biophysical differences. 
One key property of the BMCs is their ability to absorb substrate and cofactor 
molecules to allow the internalised metabolic pathway to operate. 
Adenosylcobalamin (Ado-B12) is required as a coenzyme for the diol dehydratase 
conversion of 1,2-propanediol (1,2-PD), but the uptake of cobalamin into the BMC 
was not shown. By feeding cells exogenous cobalamin, it was possible to demonstrate 
that cobalamin is specifically partitioned from the cytoplasm into the BMC. Moreover 
the synthesis of fluorescently labelled versions of cobalamin allowed this partitioning 
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1.1 Historical Context 
 
Up until relatively recently it was generally believed that compartmentalisation of 
cellular processes was a property restricted to eukaryotic life (Yeates et al., 2008). 
Compartmentalisation within eukaryotic cells was reported as early as the late 19th 
century by light microscopy studies (Alberts, 1998). Eukaryotic systems achieve 
compartmentalisation via various membrane-bound organelles including the 
mitochondria, chloroplasts, lysosomes and Golgi. Some of these organelles are 
thought to have arisen from endosymbiotic events with proteobacteria 
(mitochondria) or plastids (cyanobacteria). However, more recently some bacteria 
have been shown to contain subcellular structures called bacterial 
microcompartments (BMCs) (Kerfeld et al., 2005; Yeates et al., 2008)). 
These proteinaceous inclusion bodies, which have a regular polygonal appearance, 
were initially described in the cyanobacterium Phormidium uncinatum in 1956 by 
electron microscopy (Drews; Niklowitz, 1956; Shively et al., 1973; Yeates et al., 2008). 
Over the next 20 years similar polyhedral inclusions (in general 100-200 nm in 
diameter) were reported in various other cyanobacteria and were initially thought to 
correspond to viral capsids. The extraction and isolation of these intracellular 
polyhedral inclusions was achieved by sucrose gradient centrifugation. Electron 
microscopy of the isolated polyhedral structures suggested that they contained a 
proteinaceous envelope. The biochemical characterisation of these polyhedral 
structures revealed that the capsid encapsulates most of the cellular ribulose-1,5-
biphosphate carboxylase/oxygenase (RuBisCO), which plays a major role in global 
carbon fixation (Beudeker et al., 1980; Cannon; Shively, 1983; Turpin et al., 1984; 
Cannon et al., 1991; Bobik et al., 1999). Consequently these intracellular polyhedral 
bodies were named carboxysomes. In subsequent years carbonic anhydrase (CA) was 
also identified as a component of the carboxysomes (Price; Badger, 1989a). In the last 
decade of the 20th century, a second type of carboxysome genes was identified, 
isolated and characterised, which differentiate in genetic organisation (Price et al., 
1992). The functional and structural role of carboxysome shell proteins was validated 




using knock out strains (English et al., 1994; English et al., 1995). Shell protein knock-
outs showed that the carboxysome shell is essential for the function of the organelle. 
The isolation of the carboxysome allowed the characterisation of the shell and 
interior proteins, as well as the determination of the overall structure, function and 
biogenesis of some carboxysomes (Schmid et al., 2006; Iancu et al., 2007; Long et al., 
2007; Kinney et al., 2012; Cameron et al., 2013; Chen et al., 2013). 
Up until 1994 the protein based compartmentalisation system of the carboxysomes 
was thought to be a one-off phenomenon in prokaryotic cell biology (Chen et al., 
1994; Havemann et al., 2002; Chowdhury et al., 2014). However, a comparison of 
genomic sequences led to the identification of a carboxysomal shell protein gene 
(ccmK) homologue in an operon associated with Ado-B12 dependent 1,2-propanediol 
(1,2-PD) utilisation (Pdu) in Salmonella enterica (S. enterica). Subsequently, 
S. enterica was shown to form similar sized structures (100-150 nm) to carboxysomes 
in the presence of exogenous 1,2-PD (Bobik et al., 1999). This demonstrated that 
protein based microcompartments are involved in both anabolic processes such as 
carbon fixation, as well as catabolic processes such as Pdu (Yeates et al., 2008; Abdul-




Despite the discovery of a wide variety of bacterial protein based organelles in recent 
years, carboxysomes remain the best characterised BMC system regarding structure 
and function (Frank et al., 2013; Rae et al., 2013; Chowdhury et al., 2014). 
Carboxysomes are ubiquitous in that they are found in all bacteria using the Calvin 
cycle for CO2 fixation, including photoautotrophic cyanobacteria (a diverse group of 
photosynthetic bacteria living in fresh-water and marine ecosystems) and some 
chemoautotrophs (a diverse group of organisms using inorganic energy sources as 
e.g. hydrogen sulphide, sulphur or ferrous iron) (Kerfeld et al., 2010; Rae et al., 2013; 
Frank et al., 2013; Chowdhury et al., 2014). 





1.2.1. Why compartmentalise RuBisCO? 
 
RuBisCO has a low turnover rate of 1-13 s-1 for its substrates ribulose-1,5-biphosphate 
and CO2, which results in the formation of two molecules of 3-phosphoglycerate 
(Price et al., 2008). In addition to the low turnover of the enzyme, RuBisCO can use 
O2 as a substrate instead of CO2 in an energy wasteful oxygenation reaction called 
photorespiration. The use of O2 instead of CO2 leads to the formation of one molecule 
of 3-phosphoglycerate and one molecule of phosphoglycolate. Thus, the produced 
amount of 3-phosphoglycerate is reduced. Phosphoglycolate cannot be used in the 
Calvin cycle and therefore phosphoglycolate needs to be recycled in a series of 
reactions called photorespiration (Leegood, 2007). This results in a re-release of CO2 
and a direct cost of one ATP and one NAD(P)H molecule. The compartmentalisation 
of RuBisCO is in general thought to counteract this inborn inefficiency by enhancing 
the concentration of CO2 and reducing the concentration of O2. 
 
1.2.2. The functional role of carboxysomes to sequester the volatile CO2 and to 
form a protein scaffold 
 
Photosynthetic cyanobacteria require carbon uptake for carbon fixation (Rae et al., 
2013). Both HCO3- transporters and CO2-transporters were reported to mediate the 
uptake of inorganic carbon into the cytoplasm of cyanobacteria. This elevates the 
level of cellular HCO3- and CO2. At physiological conditions in the cytoplasm (pH 6.5) 
HCO3- is the more abundant species. 
The general suggested function of carboxysomes is outlined in Figure 1.1. The 
carboxysomal shell, which encapsulates RuBisCO and CA, which catalyses the 
conversion of HCO3-, is thought to be a selectively permeable layer (Tanaka et al., 
2008; Yeates et al., 2008; Kerfeld et al., 2010; Rae et al., 2013). It does this by acting 
as a diffusion barrier to limit CO2 efflux and O2 influx but yet permits the import of 




ribulose-1,5-biphosphate, HCO3- and CO2, and export of 3-phosphoglycerate between 
the carboxysome and the cellular cytoplasm. How this is achieved remains mainly 
unknown but carboxysome mutants unable to form intact shells require increased 
CO2 levels for growth. 
 
 
Figure 1.1. The functional role of carboxysomes. 
 
RuBisCO acts to fix the volatile CO2 into 3-keto-2-carboxyarabinitol-1,5-bisphosphate. 
The reaction product then decays spontaneously into two molecules of 3-
phosphoglycerate. In addition to forming a diffusion barrier, the carboxysome was 
suggested to act as a protein scaffold to encapsulate the enzymes CA and RuBisCO. 
In so doing the CA elevates the local CO2 levels in proximity of RuBisCO, promoting 
the efficiency of RuBisCO. 
 
1.2.3. Two types of carboxysomes 
 




Carboxysomes can be divided into two distinct types based on the associated 
RuBisCO and operon organisation (Yeates et al., 2008; Rae et al., 2013). 
ĂƌďŽǆǇƐŽŵĞƐ ŽĨ ƚŚĞ ɲ-type (carboxysome operon, cso ) ĂƌĞ ĨŽƵŶĚ ŝŶ ɲ-
ĐǇĂŶŽďĂĐƚĞƌŝĂ ?KƌŐĂŶŝƐŵƐǁŝƚŚɲ-carboxysomes contain type 1A RuBisCO and their 
ĐĂƌďŽǆǇƐŽŵĞŐĞŶĞƐĂƌĞĂƌƌĂŶŐĞĚŝŶƚŽĂƐŝŶŐůĞŽƉĞƌŽŶ ?ĂƌďŽǆǇƐŽŵĞƐŽĨƚŚĞɴ-type 
(carbon concentrating mechanism, ccm )ĂƌĞ ĨŽƵŶĚ ŝŶɴ-cyanobacteria and contain 
type 1B RuBisCO. Type 1B RuBisCO differs from 1A phylogenetically, as dŽďŽƚŚɲ-
ĐĂƌďŽǆǇƐŽŵĞƐĂŶĚɴ-carboxysomes differ in their distinct protein sets. Atypical for 
D ŽƉĞƌŽŶƐ ? ɴ-carboxysome genes are usually spread out over multiple gene 
clusters. 
 
 ? ? ? ? ? ?dŚĞƐƚƌƵĐƚƵƌĞŽĨɲ-carboxysomes 
 
1.2.4.1. BMC shell proteins form the ƐŚĞůůŽĨɲ-carboxysomes 
dŚĞ ƐŚĞůů ŽĨ ƚŚĞ ɲ-carboxysome is composed mostly of CsoS1 proteins, which are 
called CsoS1A, B, C and D (Heinhorst et al., 2006; Kerfeld et al., 2010; Kinney et al., 
2011). These proteins make up the facet or faces of the structure. As well as the CsoS1 
proteins the shell also requires the proteins CsoS4A and CsoS4B, which form the 
vertices of the structure. 
The CsoS1A-C proteins are comparatively small with a molecular mass of 10-11 kDa. 
CsoS1A-C contain the characteristic bacterial microcompartment (BMC) motif 
(pfam00936) (Tanaka et al., 2009; Kerfeld et al., 2010; Kinney et al., 2011; Yeates et 
al., 2011). Crystal structures of CsoS1A (PDB code: 2G13) and CsoS1C (PDB code: 
3H8Y) tile up to form a flat regular hexamer as shown in Figure 1.2. An important 
feature of BMC protein hexamers are central pores of a defined size and charge 
distribution. It was proposed that the positively charged pores of CsoS1A and CsoS1C 
might promote the passage of negatively charged molecules such as HCO3- and limit 
the import of uncharged O2 and efflux of CO2, but substrate bound structures are not 
available. 






Figure 1.2. The BMC shell. Single and double BMC domain proteins (green) form the facets of the 
structure. Pentameric vertex proteins (red) form the vertices of the structure. 
 
In addition to single BMC proteins, so called double (tandem) BMC proteins such as 
CsoS1D (PDB code: 3F56) form flat trimeric structures with a pseudohexameric 
symmetry (Yeates et al., 2008; Rae et al., 2013). Furthermore, X-ray crystallography 
of CsoS1D revealed that the central pore could adopt conformations representing a 
closed and open pore structure (Klein et al., 2009; Rae et al., 2013). The interchange 
between these conformations could gate the entry and exit of the relatively large 
RuBisCO substrate ribulose-1,2 biphosphate, without compromising the 
semipermeable nature of the shell. 
The geometry of the BMC shell of carboxysomes requires a specialised protein to fill 
the gaps at the vertices (Tanaka et al., 2008; Cai et al., 2009; Rae et al., 2013) ?/Ŷɲ-
carboxysomes this is achieved by CsoS4A and CsoS4B, which belong to a class of 
distinct vertex proteins (CcmL/CsoS4/ EutN/PduN BMC motif, pfam: 03319). CsoS4A 
and CsoS4B form pyramidal pentamers in crystal structures (Tanaka et al., 2008). 
Both proteins were shown to be necessary for shell closure and function of the 
carboxysomes in double knock out mutants of csoS4AB (Cai et al., 2009). 




 ? ? ? ? ? ? ? ?dŚĞŽǀĞƌĂůůƐƚƌƵĐƚƵƌĞŽĨɲ-carboxysomes 
ĂƌďŽǆǇƐŽŵĞƐĨƌŽŵƚŚĞɲ-type form regular polyhedral structures. Such icosahedral 
structures as assigned for carboxysomes consist of 20 triangular faces (Johnson; 
Speir, 1997; Schmid et al., 2006; Rae et al., 2013). Five faces meet around each of the 
12 vertices. The formation of such regular structures was suggested in 1974 after 
visualisation of negatively stained samples by TEM (Bock et al., 1974). However it was 
not until 2006 that 2D cryo-ƚŽŵŽŐƌĂƉŚƐ ŽĨ ŝƐŽůĂƚĞĚ ɲ-carboxysomes from 
Halothiobacillus neapolitanus (H. neapolitanus) were reconstructed into a regular 
icosahedral 3D model, which is shown in Figure 1.3. 
 
 
Figure 1.3. dŚĞƌĞŐƵůĂƌ ŝĐŽƐĂŚĞĚƌĂůŶĂƚƵƌĞŽĨɲ-carboxysomes from H. neapolitanus. A. Icosahedral 
ŵŽĚĞůŽĨĂƌĞĐŽŶƐƚƌƵĐƚĞĚɲ-carboxysome. B. Cryo-tomographic slice through the centre of ŝƐŽůĂƚĞĚɲ-
carboxysomes (Schmid et al., 2006). 
 
dŚĞŵŽĚĞůŚŝŐŚůŝŐŚƚƐĂƌĞŐƵůĂƌŝĐŽƐĂŚĞĚƌĂůƐŚĂƉĞŽĨŝƐŽůĂƚĞĚɲ-carboxysomes, similar 
to many viral capsids, which have common structural features but are 
phylogenetically unrelated to BMCs (Caspar; Klug, 1962; Johnson; Speir, 1997; 
Schmid et al., 2006; Tanaka et al., 2010) ?dŚĞƌĞŐƵůĂƌŶĂƚƵƌĞŽĨɲ-carboxysomes is 
supported by single particle analysis that determined a homologous size 
(100 ± 10 Ŷŵ ) ĨŽƌ ŝƐŽůĂƚĞĚ ɲ-carboxysomes from H. neapolitanus. Interestingly, 




ƚŚŽƵŐŚ ? ɲ-carboxysomes from Prochlorococcus marinus form smaller structures of 
about 90 Ŷŵ ĂŶĚ ɲ-carboxysomes of Nitrobacter agilis were reported to form 
structures with an average diameter of 120 nm (Shively et al., 1977; Van Eykelenburg, 
1980; Roberts et al., 2012; Rae et al., 2012; Rae et al., 2013). Functional roles 
associated with these size differences are not reported and the driving forces of these 
ƐƚƌƵĐƚƵƌĂů ĐŚĂŶŐĞƐ ĂƌĞ ǁŝĚĞůǇ ƵŶŬŶŽǁŶ ? ^ŝǌĞ ĚŝĨĨĞƌĞŶĐĞƐ ŽĨ ɲ-carboxysomes are 
discussed in Section  ? ? ?ǁŝƚŚƌĞƐƉĞĐƚƚŽɴ-carboxysomes. 
 
 ? ? ? ? ? ? ? ?dŚĞŝŶƚĞƌŶĂůŽƌŐĂŶŝƐĂƚŝŽŶŽĨɲ-carboxysomes 
CsoS ?ŚĂƐďĞĞŶƐƵŐŐĞƐƚĞĚƚŽƉůĂǇĂĐĞŶƚƌĂůƌŽůĞĨŽƌƚŚĞŝŶƚĞƌŶĂůŽƌŐĂŶŝƐĂƚŝŽŶŽĨɲ-
carboxysomes (Rae et al., 2013). The csoS2 gene codes for a full-length protein 
(CsoS2A, 130 kDa) and a shorter protein (CsoS2B, 85 kDa) in H. neapolitanus 
(Heinhorst et al., 2006). CsoS2 contains two protein domains with unknown functions 
but was shown to interact with several carboxysome proteins (Baker et al., 1999; 
Cannon et al., 2003; So et al., 2004; Gonzales et al., 2005; Rae et al., 2013). The rough 
1:1 stochiometry of RuBisCO to CsoS2 suggested a role in recruiting RuBisCO directly 
to the carboxysomes shell (Heinhorst et al., 2006). This would suggest a shell centred 
ƐƚƌƵĐƚƵƌĞĨŽƌɲ-carboxysomes. This hypothesis is supported by electron microscopy 
ĚĂƚĂ ƌĞƉŽƌƚŝŶŐ ŽŶ ɲ-carboxysomes with loose central packing (Baker et al., 1998; 
Menon et al., 2008; Rae et al., 2013). To conclude, the current view on the internal 
ŽƌŐĂŶŝƐĂƚŝŽŶŽĨɲ-carboxysomes suggests a shell-centred structure, which recruits CA 
directly and RuBisCO via CsoS2 but requires the elucidation of the functional role of 
CsoS2 in more detail. 
 
1.2.4.3 ?^ŝŵƵůƚĂŶĞŽƵƐĂƐƐĞŵďůǇŽĨɲ-carboxysomal shell and lumen 
dŚĞďŝŽŐĞŶĞƐŝƐŽĨɲ-carboxysomes has not been studied directly but a model was 
hypothesised from structural observations, regarding the potential interaction of 
CsoS2 with shell proteins, carboxysomal CA and RuBisCO (Price; Badger, 1989b; Price; 




Badger, 1991; Rae et al., 2013). This model suggests the simultaneous formation of 
the encased enzymes and shell assembly. 
 
 ? ? ? ? ? ?dŚĞƐƚƌƵĐƚƵƌĞŽĨɴ-carboxysomes 
 
 ? ? ? ? ? ? ? ?DƐŚĞůůďƵŝůĚŝŶŐďůŽĐŬƐŽĨɴ-carboxysomes 
ƐĨŽƌɲ-carboxysomes, the ŵĂũŽƌŝƚǇŽĨƚŚĞɴ-carboxysomal shell is formed of single 
BMC proteins (CcmK2-4, PDB: 2A1B, 2A10), which form hexameric tiles, and the 
tandem BMC shell proteins CcmO and CcmP (PDB code: 4HT5), forming trimeric 
pseudohexameric structures (Kerfeld et al., 2005; Samborska; Kimber, 2012; Rae et 
al., 2012; Rae et al., 2013). The pentameric vertex protein CcmL (PDB code: 2QW7) 
plays a more specialised role in closing the structure at the vertices (Tanaka et al., 
2008). 
 
 ? ? ? ? ? ? ? ?dŚĞŽǀĞƌĂůůƐƚƌƵĐƚƵƌĞŽĨɴ-carboxysomes 
ƐǁŝƚŚƚŚĞɲ-carboxysomes of H. neapolitanus, a similar cryo-electron tomography 
ĂƉƉƌŽĂĐŚůĞĚƚŽƚŚĞƐƚƌƵĐƚƵƌĞŽĨŝƐŽůĂƚĞĚɴ-carboxysomes from Synechococcus strain 
WH8102 (Schmid et al., 2006; Iancu et al., 2007). The ɴ-carboxysome was found to 
have an icosahedral structural topology with a size of 120 ± 10 nm in diameter, which 
reflects the regular icosahedral nature of carboxysomes. The internal organisation of 
RuBiscO suggested a tight para-crystalline packing of RuBisCO in the lumen ŽĨƚŚĞɴ-
ĐĂƌďŽǆǇƐŽŵĞƐ ?ŝŶĐŽŶƚƌĂƐƚƚŽƚŚĞůŽŽƐĞĐĞŶƚƌĂůƉĂĐŬŝŶŐŽĨZƵŝƐKƐƵŐŐĞƐƚĞĚĨŽƌɲ-
carboxysomes (Iancu et al., 2007; Rae et al., 2013). 
/ŶƚĞƌĞƐƚŝŶŐůǇ ?ƚŚĞĂǀĞƌĂŐĞĚŝĂŵĞƚĞƌŽĨɴ-carboxysomes appears to be more variable 
ŝŶĐŽŵƉĂƌŝƐŽŶƚŽɲ-carboxysomes (90-120 nm; Figure 1.3; Section 1.2.4) (Rae et al., 
2013) ? dŚĞ ĚŝĂŵĞƚĞƌ ŽĨ ɴ-carboxysomes can range from approximately 120 nm in 
Synechococcus strain WH8102, to about 175 nm in Synechococcus elongatus or more 
than 500 nm in Spirulina platensis ?dŚŝƐĚŝĨĨĞƌĞŶĐĞ ŝŶƐŝǌĞƌĂŶŐĞďĞƚǁĞĞŶɲ- ĂŶĚɴ-








Figure 1.4. Comparison of carboxysome size. (Nitrobacter agilis, Prochlorococcus marinus) are 
ĐŽůŽƵƌĞĚ ŝŶŽƌĂŶŐĞ ?ɴ-carboxysomes (Synechococcus elongatus, Spirulina platensis) are coloured in 
green. 
 
Differences in diameter size also reflect a difference in volume and outer surface 
area, which likely mirror functional and structural differences of these 
supramolecular assemblies (Rae et al., 2013). 
 




1.2.5.3. The ŝŶƚĞƌŶĂůƐƚƌƵĐƚƵƌĞŽĨɴ-carboxysomes 
dŚĞŐƌŽƵŶĚǁŽƌŬŶĞĐĞƐƐĂƌǇƚŽĚĞƚĞƌŵŝŶĞƚŚĞƐĞƋƵĞŶƚŝĂůĂƐƐĞŵďůǇŽĨɴ-carboxysomes 
came from biochemical studies determining the function of the scaffolding protein 
CcmM and the intermediary protein CcmN (Long et al., 2007; Pena et al., 2010; 
Chowdhury et al., 2014). 
Binding studies (pull down studies) suggested that the scaffolding protein CcmM-58 
(58 kDa) cross-links multiple RuBisCO and CA proteins into an extended network that 
promotes carbon fixation (procarboxysome). The N-terminus of CcmM-58 has 
sequence similarity to CA and was suggested to bind CA. The C-terminus of CcmM-58 
has three to five tandem repeats with the small subunit of RuBisCO. Binding and 
comparative studies suggest that CcmM crosslinks the metabolic enzymes for carbon 
fixation (RuBisCO and CA) (Long et al., 2007; Pena et al., 2010; Kinney et al., 2012; 
Chen et al., 2013; Cameron et al., 2013). 
The truncated C-terminal isoform CcmM-35 (35 kDa) of CcmM-58 only consists of 
three to five tandem repeats with the small subunit of RuBisCO and is supposed to 
crosslink RuBisCO in the centre of the lumen (Kinney et al., 2012). CcmM is therefore 
ƚŚŽƵŐŚƚƚŽŽƌŐĂŶŝƐĞƚŚĞůƵŵĞŶŽĨɴ-carboxysomes. 
The internalised RuBisCO-CcmM-CA procarboxysome complex is associated with the 
shell via the intermediary protein CcmN (Kinney et al., 2012; Cameron et al., 2013; 
Chen et al., 2013). The N-terminal domain of CcmN binds the encapsulated 
scaffolding protein CcmM; the C-terminal peptide of CcmN interacts with the major 
carboxysomal shell protein CcmK2 ? dŚĞ ŽƵƚĞƌ ƐŚĞůů ŽĨ ɴ-carboxysomes consists of 
CcmK2-4, CcmO and CcmP, which contain the BMC motif, and the pentameric vertex 
protein protein CcmL. Therefore, the scaffolding proteins CcmM and CcmN play 
essential roles in the biogenesis of carboxysomes and allowed the elucidation of 
carboxysome biogenesis. Due to the central role of CcmM in forming the 
ƉƌŽĐĂƌďŽǆǇƐŽŵĞ ?ɴ-carboxysomes are suggested to form lumen centred structures, 
ŝŶĐŽŶƚƌĂƐƚƚŽɲ-carboxysomes. 






In contrast to the suggested non-ƐĞƋƵĞŶƚŝĂů ĂƐƐĞŵďůǇ ŵĞĐŚĂŶŝƐŵ ĨŽƌ ɲ-
carboxysomes, biochemical and structural studies suggest a sequential assembly of 
ɴ-ĐĂƌďŽǆǇƐŽŵĞƐ ? dŚĞ ďŝŽŐĞŶĞƐŝƐ ŽĨ ɴ-carboxysomes was examined in two 
independent studies employing time-lapse fluorescence microscopy and electron 
microscopy of knock-out strains from Synechococcus PCC 7942 (Chen et al., 2013; 
Cameron et al., 2013). This determined the assembly pathway of nucleating CA with 
RuBisCO via the scaffolding protein CcmM. Next CcmN associates with the nucleated 
procarboxysome consisting of RuBisCO, CA and CcmM, followed by the recruitment 
of hexameric shell proteins (CcmK2-4), the trimers (CcmO and CcmP) and pentameric 
vertex proteins (CcmL). During shell closure, excess material of the procarboxysome 
is pinched off. The excess material then ĨƵŶĐƚŝŽŶƐĂƐĂŶƵĐůĞĂƚŝŽŶǌŽŶĞĨŽƌĨƵƚƵƌĞɴ-
carboxysome biogenesis. dŚĞ “ƉŝŶĐŚŝŶŐŽĨĨ ?process is called a budding event. 
 
1.3. The relation of carboxysomes to other bacterial microcompartments 
 
In addition to the anabolic carbon fixation process that is encapsulated within 
carboxysomes, protein based bacterial microcompartments are also found to be 
involved in a series of catabolic processes (metabolosomes) such as 1,2-PD utilisation 
and ethanolamine utilisation (Eut) (Penrod; Roth, 2006; Tsoy et al., 2009; Abdul-
Rahman et al., 2013; Chowdhury et al., 2014; Axen et al., 2014). According to several 
recent comparative genomic studies, bacterial microcompartments are a widespread 
phenomenon with up to 20-30% of eubacteria having the genomic potential to form 
such supramolecular assemblies and sequester metabolic pathways (Abdul-Rahman 
et al., 2013; Axen et al., 2014). Indeed, BMC loci have been identified in 23 different 
bacterial phyla, representing around 30 distinct BMC loci and subtypes were 
identified, many with only partly known metabolic functions. 




The comparative genomic approaches have reported on catabolic BMCs, which are 
involved in the metabolism of 1,2-PD, choline, ethanol, ethanolamine, fucose and 
rhamnose. It also appears that BMCs are involved in other processes that are still to 
be determined. Despite this diversity of functional roles in anabolic and catabolic 
processes, BMC associated processes all appear to include volatile or cytotoxic 
intermediates. Furthermore, common genes are found associated with 
metabolosomes e.g. genes for aldehyde dehydrogenase (94%), alcohol 
dehydrogenase (76%), phosphotransacylase (66%) and genes encoding for proteins 
that are potentially associated with filament based organelle movement (68%) are 
very common and conserved along functionally divergent catabolic BMC loci and 
subtypes. In this respect, it also appears that structural proteins forming the BMC 
shell are conserved fƌŽŵ ɲ- and ɴ-carboxysomes through to catabolic 
metabolosomes as shown for Pdu and Eut metabolosomes in Figure 1.5. Because 
they are formed from very similar shell proteins, it was initially suggested that 




Figure 1.5. Phylogenetically conserved BMC domains. BMC domain proteins forming hexameric or 
pseudohexameric structures are coloured in green. The pentameric vertex protein domain class 
CcmL/CsoS4/EutN/PduN proteins are coloured red (Frank et al., 2013). 
 




1.4. 1,2-Propanediol utilising (Pdu) metabolosomes 
 
Pdu microcompartments are the best studied catabolic BMC model system beside 
the structurally and functionally related ethanolamine utilising (Eut) metabolosomes 
(Chowdhury et al., 2014). Both are supposed to protect the cell from a cytotoxic 
aldehyde intermediate and to encapsulate metabolic enzymes for Pdu or Eut 
degradation. In addition, both share their requirement for an Ado-B12 dependent 
enzymatic step and a proposed BMC associated reactivation of Ado-B12. Functional 
aspects of metabolic enzymes and several crystal structures of Pdu and Eut BMC shell 
proteins have been reported, but little information is available concerning the overall 
structure, assembly and internal structural organisation of catabolic BMCs 
(Havemann; Bobik, 2003; Wheatley et al., 2013; Chowdhury et al., 2014). Similarly, 
little is known about transport of prosthetic groups such as Ado-B12 across the shell, 
although this aspect is partly addressed later in this thesis (Chapter 5). 
 
1.4.1. Ecology and distribution of 1,2-PD degradation 
 
1,2-PD is an important anaerobic breakdown product of the common plant sugars 
fucose and rhamnose (Toraya et al., 1979; Obradors et al., 1988). The degradation of 
1,2-PD results in the formation of 1-propanol and propionate. The metabolism of 1,2-
PD therefore has an important ecological role in the degradation of plant sugars in 
the soil (Frank et al., 2013; Chowdhury et al., 2014). Furthermore, Pdu has been 
suggested to play a role in pathogenesis in the human gut where 1,2-PD can be 
respired with tetrathionate (Conner et al., 1998; Thiennimitr et al., 2011). In this 
respect, genetic studies have confirmed the presence of pdu operons in enteric 
bacteria such as Citrobacter, Clostridium, Klebsiella, Lactobacillus, Lactococcus, 
Listeria, Salmonella, Yersinia and at least one E. coli (E24377A) strain (Chowdhury et 
al., 2014). 
 




1.4.2. The pdu operon 
 
The genes encoding for the Pdu BMC shell, metabolic enzymes, cofactor reactivation 
and regulation are organised into a single operon in S. enterica (Chen et al., 1994; 
Bobik et al., 1999). The Pdu transcription factor gene (pocR) and 1,2-PD diffusion 
facilitator (pduF) gene are divergently transcribed from the main pdu operon, which 
encodes for 22 pdu genes (pduABCDEGHJKLMNOPQSTUVWX, Figure 1.6) (Bobik et 
al., 1992; Rondon; Escalante-Semerena, 1992)). 
 
 
Figure 1.6. The pdu operon organisation. Gene names are coloured according to their functional role. 
The transcription direction is shown by black arrows. 
 
In contrast to the comparatively simple two step pathway found in carboxysomes (CA 
and RuBisCO), the main pdu operon encodes for seven metabolic pathway enzymes 
(PduCDELPQW) and four Ado-B12 reactivation factors (PduGHSO) (Cheng et al., 2008; 
Frank et al., 2013). Thus, the catabolic Pdu BMCs, which form structures with a 
diameter of 100-150 nm, with a suggested molecular mass of 600 MDa and 18,000 
individual polypeptides of 18-20 types, likely represent the most complex protein 
assemblies found in bacteria. 
In addition to the metabolic enzymes for Pdu and Ado-B12 reactivation, the pdu 
operon encodes for structural BMC proteins that form the proteinaceous envelope 
(PduABJKNTU) (Havemann et al., 2002; Havemann; Bobik, 2003). PduM has no BMC 




domain but has been suggested to play a structural role because pduM knock-out 
mutants were proposed to be impaired in BMC formation (Sinha et al., 2012). PduV 
is an AAA GTPase family member and is thought to play a role in the filamentous 
movement of the BMCs to position it in the cell and during cell division (Parsons et 
al., 2010a). PduX has a role in Ado-B12 biosynthesis and is not a component of the 
BMC (Havemann; Bobik, 2003; Fan; Bobik, 2008). 
 
1.5. The functional role of Pdu metabolosomes 
 
1.5.1. Pdu BMCs sequester a cytotoxic compound 
 
One proposed function of the Pdu metabolosome is to sequester the intermediate 
propionaldehyde, which is known to be cytotoxic (Cheng et al., 2008; Rae et al., 2013; 
Chowdhury et al., 2014). In agreement with this hypothesis, BMC mutants unable to 
form Pdu metabolosome structures, or limited in propionaldehyde metabolism in 
S. enterica, accumulate propionaldehyde in the growth medium when grown on 1,2-
PD (Havemann et al., 2002; Sampson; Bobik, 2008). Mutant strains undergo a 20 h 
growth arrest due to propionaldehyde toxicity. Increased mutation rates were also 
reported for these mutant strains (Cheng et al., 2011; Chowdhury et al., 2014). 
Therefore, propionaldehyde is suggested to be cytotoxic by increasing mutation rates 
in S. enterica. Mutants disabled in BMC formation and polA (DNA repair polymerase) 
are unable to grow on 1,2-PD in S. enterica (Chowdhury et al., 2014). Further studies 
used the characteristic growth arrest on 1,2-PD to describe the functionality of BMC 
knock-out mutants (Cheng et al., 2011; Chowdhury et al., 2015). 
 
1.5.2. The BMC associated degradation pathway for 1,2-PD 
 




As well as the sequestration of a cytotoxic intermediate, the BMC encapsulates 
enzymes for the utilisation of 1,2-PD, which can serve as an ATP and carbon source 
under aerobic conditions. For function, the Pdu metabolosome needs to acquire its 
substrate 1,2-PD, a multitude of cofactors (Ado-B12, ATP CoA and NAD+) and export 
metabolic products (1-propanol, propionyl-phosphate and propionyl-CoA) (Bobik et 
al., 1997; Frank et al., 2013; Huseby; Roth, 2013; Chowdhury et al., 2014). How this 
is achieved remains largely unknown, although some insights have been gained on 
diffusion and transport processes based on the structural characterisation of a 
number of the BMC shell proteins by X-ray crystallography (Section 1.6). The cellular 
accumulation of propionaldehyde is reported to induce toxicity, which leads to a 
growth arrest (Cheng et al., 2008; Cheng et al., 2011). Therefore, the catalysis of 
encased enzymes is suggested to improve the detoxification of the accumulated 
aldehyde intermediate. Propionaldehyde is metabolised to propionyl-CoA by 
propionaldehyde dehydrogenase (PduP) or alternatively is reduced to 1-propanol by 
1-propanol dehydrogenase (PduQ). 
Propionyl-CoA is converted to propionyl-phosphate by the phosphotransacylase 
PduL. A propionate kinase (PduW) generates one molecule of ATP by substrate level 
phosphorylation of propionyl-phosphate to propionate. Alternatively, propionyl-CoA 
can feed directly into the methyl-citrate pathway under aerobic conditions (Horswill; 
Escalante-Semerena, 1997; Horswill; Escalante-Semerena, 1999). In the methyl-
citrate pathway, propionyl-CoA is fused to oxaloacetate to form methyl-citrate, which 
is converted to succinate and pyruvate. Pyruvate is metabolised further to acetyl-
CoA, which enters the tricarboxylic acid cycle. Mutations within the methyl-citrate 
pathway locus of S. enterica prevent the use 1,2-PD as a sole carbon source under 
aerobic conditions (Palacios et al., 2003). 
Anaerobically, the disproportionation of propionaldehyde into propionyl-CoA and 1-
propanol allows for redox balancing. Obviously, under fermentative conditions 1,2-
PD does not serve as a sole carbon source for S. enterica (Price-Carter et al., 2001). 
Nonetheless growth on 1,2-PD is reported to increase the cell yield by providing ATP 
(Lawrence; Roth, 1996; Liu et al., 2007). 






Figure 1.7. Pdu metabolosomes associated 1,2-PD degradation pathway. 
 
1.5.3. A potential additional role of the BMC in cofactor balancing of NAD+/H and 
CoA and internal reactivation of Ado-B12. 
 
1.5.3.1. Cofactor balancing. 
On top of the suggested roles of the Pdu BMC in sequestering the cytotoxic 
propionaldehyde and metabolic enzymes for Pdu, the BMC is thought to optimise the 
reaction environment in the lumen via cofactor balancing and cofactor reactivation 
(Figure 1.7) (Havemann; Bobik, 2003; Cheng et al., 2012; Liu et al., 2015). 
Enzymatic assays on isolated Pdu metabolosomes suggested a role for PduQ in 
supporting the activity of PduP by providing NAD+ (Cheng et al., 2012). In a similar 
fashion, PduL is suggested to recycle CoA for the activity of PduP in the lumen of the 




BMC. However, the latter suggestion is not supported by enzymatic assays or 
confirmation of the internal localisation of PduL (Liu et al., 2015). Cofactor recycling 
by PduQ and PduL is likely to improve 1,2-PD degradation. It has been suggested that 
the Pdu BMC contains and recycles private cofactor pools of NAD+ and CoA which are 
encapsulated in the lumen during self-assembly (Huseby; Roth, 2013). This was 
suggested from growth phenotypes and computational models for the related Eut 
metabolosomes. Huseby and Roth further suggest that ethanolamine ammonia-lyase 
(EutBC), which plays a similar functional role to PduCDE is associated on the outside 
of the structure, instead of the inside, where EutBC injects the reaction product 
acetaldehyde into the lumen. This contradicts the general hypothesis that BMCs 
encapsulate their metabolic enzymes. However, the study by Huseby and Roth does 
exemplify two major issues in the investigation of BMC structures in general: (I) the 
localisation of metabolic enzymes and (II) the diffusion or transport mechanisms 
required to transverse the shell. 
 
1.5.3.2. Ado-B12-reactivation 
In addition to the potential capability of the BMC to recycle cofactors, the Pdu BMC 
encodes for reactivation factors for Ado-B12. This is needed because Ado-B12 
periodically loses its adenosyl group during the dehydration of 1,2-PD, which leads to 
the formation of an inactive [OH-B12-PduCDE] complex (Kazutoshi et al., 1982; 
Toraya, 2000). The inactive complex is reactivated by freeing the OH-B12 from the 
apo-PduCDE by the action of the reactivase PduGH. Holo PduCDE reassociates with 
Ado-B12. The OH-B12 is reduced to cob(I)alamin by PduS, a cobalamin reductase. The 
final step is catalysed by the adenosyltransferase PduO, which results in the 
formation of Ado-B12 (Escalante-Semerena et al., 1990; Fonseca; Escalante-
Semerena, 2000; Fonseca; Escalante-Semerena, 2001). The proteomic analysis of 
isolated Pdu metabolosomes from S. enterica has confirmed the presence of all the 
required reactivating enzymes (PduGH, PduS and PduO) in isolated BMC fractions 
(Havemann; Bobik, 2003; Cheng; Bobik, 2010; Parsons et al., 2010b; Cheng et al., 
2012). 





1.6. The structure of the Pdu BMC 
 
1.6.1. The building blocks of the BMC shell 
 
The shell of Pdu metabolosomes is composed of seven different shell proteins: PduA, 
PduB with PduB`, PduJ, PduK, PduN, PduT and PduU, as shown in Figure 1.8 (Frank et 
al., 2013). PduA, PduJ, PduK and PduU are single BMC domain shell proteins 
(Havemann; Bobik, 2003; Yeates et al., 2011; Cheng et al., 2011). PduB, its N-terminal 
truncated isoform PduB`, and PduT contain two BMC motifs. Thus, PduB and PduT 
are fused shell proteins. PduN is closely related to other pentameric vertex proteins 
(Wheatley et al., 2013). As outlined in Figure 1.8, crystal structures are available for 




Figure 1.8. Schematic illustration of Pdu shell proteins. 
 
1.6.1.1. The canonical BMC shell protein PduA 
PduA is a single BMC domain protein (94 amino acids in S. enterica) and forms a 
hexameric structure with a distinct central pore (PDB code: 3NGK) (Havemann; Bobik, 
2003; Frank et al., 2013; Chowdhury et al., 2014). Immunolabelling suggests that 
PduA is incorporated into the Pdu metabolosome shell of S. enterica (Havemann et 




al., 2002). The central pore of a PduA hexameric tile is thought to allow the 
movement of 1,2-PD into the compartment, as the pore size of 5.6 Å is large enough 
to permit the movement of 1,2-PD without having to undergo any major 
conformational changes (Crowley et al., 2010; Pang et al., 2014; Chowdhury et al., 
2015). Hydrogen bond donors and acceptors in the PduA pore could help to bind the 
two hydroxyl groups of 1,2-PD and facilitate transport. Propionaldehyde is more 
apolar than 1,2-PD and has only 1 hydrogen bond acceptor and no donors. Thus, the 
efflux of cytotoxic propionaldehyde is limited from Pdu metabolosomes. PduA is 
thought to contribute to the flat faces of the overall structure. 
PduA hexamers form a continuous 2D layer without any gaps in the crystal, 
suggesting strong interactions between the hexamers (Crowley et al., 2010; Pang et 
al., 2014; Chowdhury et al., 2015). 
 
1.6.1.2. PduJ is related to PduA but functionally divergent 
PduJ is closely related to PduA (>80% sequence identity) (Cheng et al., 2011). No 
crystal structure of PduJ is available to date but knock-out mutants of pduJ indicate a 
structural requirement in Pdu metabolosomes of S. enterica. Elongated structures 
were observed for knock-out mutants of pduJ. As a consequence, a structural role for 




1.6.1.3. The double BMC domain shell protein PduBB` might form a gated pore 
Proteomic approaches have confirmed that pduB encodes two isoforms with an 
alternative start leading to a truncated version of PduB called PduB`, lacking 37 amino 
acids of the N-terminus in S. enterica (Havemann; Bobik, 2003; Parsons et al., 2010a). 
The function of the truncation is not reported (Parsons et al., 2010a). As for other 




tandem BMC shell proteins, a gated pore with a functional role in cofactor transport 
has been mooted (Tanaka et al., 2010; Pang et al., 2012; Thompson et al., 2014). 
The crystal structure of PduB from Lactobacillus reuteri (PDB code: 4FAY,) showed 
trimeric flat hexagons analogous to other reported tandem BMC domain proteins. 
PduB forms 2D protein sheets in crystals (Pang et al., 2012). Edge contacts between 
PduB hexamers are slightly out of alignment, which potentially reduces the sheet 
stability but is likely to increase the flexibility in the assembled structure. The crystal 
structure shows a closed central pore and three smaller pores. The large pore was 
proposed to accommodate the transport of large cofactors as e.g. ATP, NAD/H, CoA 
or Ado-B12 (Tanaka et al., 2010; Pang et al., 2012). The smaller pores are predicted to 
mediate the transport of the BMC substrate 1,2-PD (Sagermann et al., 2009; Pang et 
al., 2012). 
 
1.6.1.4. PduK has a C-terminal domain of unknown function 
PduK is a single-BMC domain shell protein of 160 amino acids in length. The PduK 
BMC domain has a C-terminal extension (~70 amino acids) with a recognisable [Fe-S] 
cluster binding motif (CNLCLDPKCPRQKGEPRTLC) (Crowley et al., 2010; Cheng et al., 
2011). Purified PduK binds iron, supporting the presence of a Fe-S centre. A potential 
role in electron transfer was therefore suggested, however no evidence for an intact 
Fe-S cluster has actually been provided. 
 
 
1.6.1.5. PduN is a pentameric vertex protein 
PduN is related to other pentameric vertex proteins such as EutN, CsoS4 and CcmL. 
PduN knock-out mutants in S. enterica form a variety of morphologies including 
elongated, enlarged and aggregated BMCs, all of which are associated with a growth 
arrest, corresponding to dysfunctional Pdu metabolosomes (Cheng et al., 2011; 
Chowdhury et al., 2014). Due to its low abundance, the association of PduN with the 




BMC was only confirmed by western blot analysis, GFP labelling and tandem mass 
spectrometry (Parsons et al., 2010a; Cheng et al., 2011; Sinha et al., 2012). Such low 
abundance is expected because of the predicted specialised structural role of PduN 
as a vertex protein (Parsons et al., 2010a; Sinha et al., 2012). 
 
1.6.1.6. PduT has a Fe-S cluster instead of a central pore 
PduT is a double-BMC shell protein with 184 amino acids (Havemann; Bobik, 2003; 
Crowley et al., 2010; Pang et al., 2011). Crystallographic studies revealed that PduT 
(PDB code: 3N79) is a homotrimer with pseudohexameric symmetry. In contrast to 
other BMC domain proteins, PduT crystals did not form 2D layers. Interestingly, the 
pore of PduT is thought to contain a Fe-S centre, which is proposed to play a role in 
electron transport or as a Fe-S insertase (Parsons et al., 2008). 
 
1.6.1.7. WĚƵhŚĂƐĂɴ-barreled pore 
Crystallised PduU (PDB code: 3CGI) from S. enterica shows a unique circularly 
permuted BMC fold. The hexagonal layers are not well packed and have a tendency 
to form strips of side by side hexamers in crystal structures (Crowley et al., 2008). 
This suggests weak interactions between PduU hexamers. The unusual six stranded 
ƉĂƌĂůůĞůɴ-barrel of PduU in ƚŚĞĐĞŶƚƌĂůƉŽƌĞŵĂŬĞƐŝƚƐƚƌƵĐƚƵƌĂůůǇƵŶŝƋƵĞďĞĐĂƵƐĞɴ-
barrel strands usually consist of a higher number of strands (e.g. 12 in 
transmembrane proteins). 
 
1.6.2. Internal organisation of Pdu metabolosomes and the protein-protein 
network. 
 




1.6.2.1. Targeting sequences are thought to mediate the encapsulation of 
metabolic enzymes 
/ŶĂĚĚŝƚŝŽŶƚŽƚŚĞĐŚĂƌĂĐƚĞƌŝƐĂƚŝŽŶŽĨɴ-carboxysome scaffolding proteins CcmM and 
CcmN, discussed in Section 1.2, N-terminal extensions of PduD and PduP were found 
to help encapsulation of metabolic enzymes within Pdu metabolosomes (Section 1.5) 
(Fan et al., 2010; Fan; Bobik, 2011; Fan et al., 2012; Choudhary et al., 2012; 
Chowdhury et al., 2014; Jakobson et al., 2015). N-terminal extensions of PduD 
(PduD18 and PduD60) and PduP (PduP18) are not required for the enzymatic activity 
but share a common hydrophobic motif, which appears to be conserved across the 
Eut and glycyl radical protein BMC systems. In silico studies suggest an interaction 
between the targeting sequences of PduD and PduP with C-terminal extensions on 
the BMC shell proteins PduA, PduJ and PduK. This interaction was shown by pull down 
assays of PduA and PduJ with PduP from S. enterica (Fan et al., 2010; Fan et al., 2012). 
A second study reported on the association of PduK and PduP in pull down studies 
from C. freundii (Lawrence et al., 2014). Thus, the association of BMC shell protein 
with PduP supports an interaction of shell proteins with encapsulated enzymes. Key 
residues for the encapsulation of PduP (E7, I10 and L14) were identified via alanine 
scanning mutagenesis  ?<ŝŵ ? dƵůůŵĂŶ ?ƌĐĞŬ ?  ? ? ? ? ). More recently, the in-solution 
structure (by NMR) of PduP18 from C. freundii suggested an amphiphilic and helical 
structure of the peptide (Lawrence et al., 2014).  
As with the targeting sequences of PduD and PduP, an N-terminal targeting sequence 
was postulated for PduL (Liu et al., 2015). However the majority of incorporated Pdu 
BMC proteins do not appear to have obvious non-enzymatic extensions or targeting 
sequences. This suggests additional incorporation mechanisms to the role of helical 
amphiphilic targeting sequences (Frank et al., 2013; Chowdhury et al., 2014). 
 
1.6.2.2. The Pdu BMC interactome 
One possible way to incorporate multiple proteins within a BMC shell via few 
targeting sequences is the formation of protein-protein complexes of internalised 
proteins. Proteomic analysis of isolated Pdu BMCs from S. enterica identified the 




presence of the following Pdu BMC proteins PduA-B-CDE-GH-K-L-M-N-O-P-Q-S-T-U-V 
(Havemann; Bobik, 2003; Sinha et al., 2012). PduCDE and PduGH are reported to form 
protein complexes for the Ado-B12 dependent 1,2-PD dehydratase and dehydratase 
reactivase, respectively (Bobik et al., 1997; Havemann; Bobik, 2003). Pull down 
studies indicate interactions between enzymes such as PduP with PduQ (Cheng; 
Bobik, 2010; Cheng et al., 2012). Pull down assays also highlighted interactions of the 
BMC shell protein PduT with PduS of S. enterica (Cheng et al., 2012). Bacterial two 
hybrid studies infer interactions between PduS and PduO. 
 
1.6.3. The overall structure of Pdu metabolosomes 
 
Relatively little is known about the assembly of catabolic BMCs. This is due to the high 
degree of complexity associated with their formation, which is demonstrated by the 
involvement of 18-20 proteins in comparison to carboxysomes where 10-11 proteins 
are ŝŶǀŽůǀĞĚ ŝŶƚŚĞĂƐƐĞŵďůǇŽĨɲ-carboxysomes as in H. neapolitanus (Havemann; 
Bobik, 2003; Rae et al., 2013). Furthermore, it appears that Pdu metabolosomes from 
S. enterica are more heterogeneous (120 ± 30 nm) in size and shape than their 
anabolic counterparts from H. neapolitanus (90 ± 10 nm), as evidenced in Figure 1.9 
(Corchero; Cedano, 2011; Tocheva et al., 2014). These features complicate the 
analysis of the structural properties of Pdu BMC structures. 
 





Figure 1.9. Isolated Pdu microcompartments. A. ĞŶƚƌĂůƐůŝĐĞŽĨɲ-carboxysomes in cryo-tomography 
(Schmid et al., 2006). B. Isolated Pdu metabolosomes from S. enterica in negative stain TEM (Sinha et 
al., 2012). 
 
1.7. Work leading up to this project 
 
1.7.1. The recombinant formation of BMCs in E. coli 
 
The sequestration of metabolic processes is a desired feature for nano-
biotechnological applications, for example, in the production of fine-chemicals 
including volatile or cytotoxic intermediates (Chessher et al., 2015). One prerequisite 
for the application of BMCs in synthetic biology is the ability to form recombinant 
BMC structures. In this manner E. coli was empowered with the ability to form 
functional recombinant Pdu BMCs (rBMCs) from C. freundii (Parsons et al., 2008). 
E. coli harbouring the pdu operon were able to metabolise 1,2-PD as determined by 
a McConkey agar plate. Furthermore, diol dehydratase assays were conducted to 
confirm the activity for 1,2-PD degradation in crude cell lysates. In addition to this 
gain of function, E. coli was shown to form polygonal Pdu metabolosomes (108-




123 nm diameter) with a similar size to S. enterica as determined by negative stain 
TEM and SuperSTEM (aberration corrected non-contrast electron microscope) of 
ŝƐŽůĂƚĞĚ ƐƚƌƵĐƚƵƌĞƐ ? DŽƌĞ ƌĞĐĞŶƚůǇ ? ƚŚĞ ŐĞŶĞƚŝĐ ŝŶĨŽƌŵĂƚŝŽŶ ĨŽƌ ɲ-carboxysome 
formation from H. neapolitanus was transferred to E. coli to study the assembly of 
recombinant carboxysomes (Bonacci et al., 2012) ?dŚĞƌĞĐŽŵďŝŶĂŶƚĨŽƌŵĂƚŝŽŶŽĨɲ-
carboxysomes and Pdu BMCs suggest that BMC formation is a tractable system, 
which can assist the analysis of structure and function of BMCs. However, the 
recombinant BMCs have not been properly compared to native BMCs from the host 
organism (C. freundii or H. neapolitanus). 
 
1.7.2. The recombinant formation of empty Pdu based microcompartments 
 
The potential biotechnological application of BMCs for synthetic biology requires 
stripping the BMC of its internal cargo and to reintroduce non-native metabolic 
pathways. To achieve this, an artificial operon harbouring only the Pdu BMC shell 
protein genes (pduA-B-J-K-N-U-T, A-T) was constructed (Parsons et al., 2010a). The 
ĞǆƉƌĞƐƐŝŽŶ ŽĨ Ăůů D ƐŚĞůů ƉƌŽƚĞŝŶƐ ůĞĚ ƚŽ ƚŚĞ ĨŽƌŵĂƚŝŽŶ ŽĨ ƐŽ ĐĂůůĞĚ  “ĞŵƉƚǇ
ŵŝĐƌŽĐŽŵƉĂƌƚŵĞŶƚƐ ? ?ĞDƐ ) ?dŚĞƐĞĞŵƉƚǇDƐǁĞƌĞĂďůĞƚŽĨŽƌŵŝŶƚŚĞĂďƐĞŶĐĞ
of any metabolic enzymes or enzymes for Ado-B12 reactivation. Furthermore, the 
reduction of Pdu BMC shell protein genes from A-T to A-U or A-N did not disrupt BMC 
shell assembly. The ability of such eBMC (A-U) structures to recruit pathway enzymes 
was demonstrated by fusing GFP to the C-terminus of PduC, PduD and PduP, which 
resulted in the regio-specific targeting of GFP-fusions to the eBMC. The study by 
Parsons et al. provided the ground-work to construct a BMC based bioreactor, 
forming a proteinaceous encasement by the coordinated expression of Pdu BMC shell 
proteins without characterising the assembly itself (Lawrence et al., 2014). 
 
1.7.3. The construction of a BMC based ethanol bioreactor 
 




To utilise the capability of eBMCs for metabolic engineering, metabolic enzymes for 
ethanol formation were targeted to the stripped eBMC shell (A-U) (Parsons et al., 
2010a; Lawrence et al., 2014). To allow this the N-terminus of pyruvate decarboxylase 
(Pdc) was labelled with the PduP18 (18 amino acids of the N-terminus of PduP) 
targeting sequence and the alcohol dehydrogenase (Adh) was fused onto the C 
terminus of PduD18 or PduD60 (18 or 60 amino acids of the N-terminus of PduD; 
Section 1.6.2.1). Both genes (Adh and Pdc) were cloned from Zymomonas mobilis. 
The resultant strain, containing PduA-U plus PduP18-Pdc and PduD60-Adh, allowed 
the formation of ethanol bioreactors that showed increased production level of 
ethanol. Isolated ethanol bioreactors were tested for the coupled enzymatic activity 
for ethanol production and showed a 20 fold increase in activity of isolated eBMCs in 
comparison to crude lysate samples. The formation of an ethanol bioreactor based 
on Pdu BMCs provides a proof of concept study, showing that BMCs in general can 
be manipulated to sequester relevant industrial metabolic pathways. 
  




1.8. Aims and Objectives 
 
Despite recent advances in the application of Pdu BMC based eBMCs, structural and 
functional properties of wild type, rBMC and eBMC variants have not been reported. 
Therefore, this study aims to compare the structure of eBMCs and rBMCs to their 
wild type compartments through the application of TEM and AFM. Initially, 
purification protocols were developed and compared for eBMC, rBMC and wild type 
structures to allow the quantitative analysis of BMC shell building blocks by a 
proteomic approach consisting of 2D-PAGE, MALDI TOF-TOF and densitometric 
measurements. In part, the biophysical properties of the BMCs were compared in 
order to detect any differences in terms of size (TEM and AFM) and height (AFM). The 
application of AFM has yielded in a more detailed analysis of mechanical properties. 
A TEM technique was applied, that permitted the study of the internal organisation 
of all the various Pdu BMC structures (eBMC, rBMC and wild type). In addition to 
these proteomic and biophysical studies, LC-MS based methods were developed to 
study qualitative and quantitative effects of cobalamin in presence of BMCs (in vivo 
and in vitro). For visualisation in wide field microscopy, fluorescent B12-analogues 
needed to be generated, purified and characterised. 
  







Materials and methods 





2.1. Materials  
 
Most chemicals and antibiotics were purchased from Sigma-Aldrich Ltd. Other materials were 
purchased from manufacturers as follows: IPTG and ampicillin from Melford Laboratories 
Ltd; chelating fast flow Sepharose, disposable from GE Healthcare; QIAprep® Spin Miniprep 
Kit from Qiagen, restriction enzymes were purchased from Promega and from New England 
Biolabs Inc.; tryptone, yeast extract and bacterial agar from Oxoid Ltd. 
 
2.2. Bacterial strains 
 
Table 2.1. Bacterial strains 
Organism Strain Genotype and/or phenotype Reference 
E. coli BL21 (DE3) F - ompT hsdSB (rB - , mB - ) 
gal dcm (DE3) 
Novagen 
E. coli BL21 (DE3) pLysS F - ompT hsdSB (rB - , mB - ) 
gal dcm (DE3) pLysS (CmR ) 
Novagen 
E. coli DH5-ɲ F - ੮ ? ?ůĂĐA?D ? ?A? ?ůĂĐz-
argF) U169 recA1 endA1 
hsdR17 (rK-,mK+) phoA 
ƐƵƉ ? ?ʄ- thi- 1 gyrA96 relA1 
Invitrogen 
C. freundii C. freundii 
ballerup 7851 
wild type (wt) Sanger Institute 
S. typhimurium  S. typhimurium 
(AR2680) 
cbiB and metE mutant, 
blocking synthesis of 
coenzyme-B12 (cbiB) and 
methionine (metE), indicator 
strain for B12 quantification 
(Raux et al., 
1996) 
  






Table 2.2. Plasmid list 
Name Plasmid Description Reference or 
source 
pET3a pET3a Overproduction 
vector with T7 
promoter, Ampr 
Novagen 
pET14b pET14b Overproduction N-
terminal His6tag 
fusion protein vector 
with T7 promoter, 
Ampr 
Novagen 
pLysS pLysS Overproduction 
vector with T7 
promoter, Camr 
Promega 
btuB pLysS-btuB Overproduction of the 
outer transmembrane 
cobalamin transporter  
Provided by Dr. 
Evelyne Deery 
btuB pET3a-btuB Overproduction of the 
outer transmembrane 
cobalamin transporter 
Provided by Dr. 
Evelyne Deery 
cobN pET14b-cobN Overproduction of N-
terminal His6tag CobN 
Provided by Dr. 
Evelyne Deery 
cobR pET14b-cobR Overproduction of N-
terminal His6tag CobR 
Provided by Dr. 
Evelyne Deery 

















provided by Dr. 
Stefanie Frank 
A-T pET3a-ABJKNUT Formation of empty 
Pdu 
microcompartments 














2.4. Solutions and buffers 
 
2.4.1. Media and solutions for bacterial work 
 
Luria-Bertani (LB) broth     Tryptone  10 g 
Yeast extract  5 g 
NaCl   5 g 
Made up to 1 L with dH2O and autoclaved.  
2YT broth      Tryptone  16 g 
Yeast extract  10 g 
NaCl   5 g 
Made up to 1 L with dH2O and autoclaved. 
 
Luria-Bertani agar 




10x M9 salts:      Na2HPO4  60 g 
       KH2PO4   30 g 
       NH4Cl   10 g 
       NaCl   5 g 
Made up to 1 L with dH2O and autoclaved 
 
Mg2+ stock      MgSO4(H2O)7  1 M 
Brought up to final volume with dH2O and autoclaved. 
 




50x NCE: Chemicals were dissolved one at a time in the order listed below, allowing each to 
dissolve completely. Heated 330 mL dH2O on stirring block (not boiled). 
       KH2PO4    197 g 
       K2HPO43H2O   323 g 
       NaNH4HPO44H2O 175 g 
Brought to 1 L with dH2O and autoclaved. 
 
NCE liquid medium: 
50x NCE  20 mL 
1 M MgSO4  1 mL 
 
Sterile 1,2-PD and carbon source were added and the solution brought to 1 L with dH2O. 
 
2.4.2. Antibiotics and additives 
 
Table 2.3. Antibiotics and additives 
Antibiotics/Additives Stock concentration Final concentration 
Ampicillin 100 mg mL-1 in EtOH 100 µg mL-1 
IPTG 1 M in dH2O 100 µM 
Chloramphenicol 34 mg mL-1 in EtOH 34 µg mL-1 
 
2.4.3. Solutions for DNA work 
 
TAE buffer:     Tris-HCl, pH 8.0   10 mM 
      EDTA, pH 8.0   1 mM 
 
6x DNA loading buffer    Bromophenol blue (w/v) 0.25% 
Glycerol (v/v)   50% 
TAE buffer (v/v)   50% 





Figure 2.1. Hyperladder 1 kb (Bioline): 5 ʅ> applied to a 1% (w/v) TBE/agarose gel visualised using 
ethidium bromide. 
 
2.4.4. Solutions used for protein work 
 
      
2.4.4.1. Solutions for BMC purification (B-WZ ?) 
Buffer A     Tris-HCl, pH 8.0  50 mM 
      KCl   500 mM 
      MgCl2   12.5 mM 
 
Buffer B     Tris-HCl, pH 8.0  50 mM 
      KCl   50 mM 
      MgCl2   5 mM 
 
2.4.4.2. Solutions for eBMC purification (Y-WZ ?): 
Resuspension buffer    Tris-HCl, pH 8.0  20 mM 
      NaCl   20 mM 




2.4.4.3. Solutions for protein polyacrylamide gel electrophoresis.  
10x running buffer:    Tris   30 gL-1 
      Glycine   144 gL-1 
1% (w/v) SDS added to 1x running buffer for SDS gels 
 
2x SDS sample buffer   0.5 M Tris-HCl, pH 6.8 6.0 mL 
     Glycerol  4.8 mL 
     SDS 10% (w/v)  9.6 mL 
     Bromophenol blue 1.2 mL 
     dH2O   24 mL 
 ? ?ʅ>ɴ-mercaptoethanol added per mL 2x SDS sample buffer. 
 
Denaturing molecular weight marker- Dalton VII (Sigma): 
Protein molecular weight (kDa): 66, 45, 36, 29, 20.1, 14.2 
 
Denaturing molecular weight marker- Prestained protein marker, broad range (New 
England BioLabs); Molecular weight (kDa): 175, 80, 58, 46, 30, 25, 17 and 7 
 
Denaturing molecular weight marker- Blue protein standard, broad range (New England 
BioLabs): Molecular weight (kDa): 190, 135, 100, 75, 58, 46, 32,  25, 22, 17, 11 
 
Coomassie blue stain:   TCA 100% (w/v)  250 mL 
     Coomassie blue R250 0.60 g 
     SDS   0.10 g 
     Tris-HCl   0.25 g 
    Glycine   0.15 g 
Made up to 500 mL with dH2O 
 




Table 2.4. Gel composition for SDS-PAGE and 2D-PAGE 
SDS gels 
Running gels 12.5% 15% Stacking gel 5% 
dH2O (mL) 3.4 2.2 dH2O (mL) 3.4 
30% Acrylamide 
 ?ŵ> ?ĐƌǇů ?ŝƐ ?
29:1 
6.3 7.5 30% Acrylamide 
 ?ŵ> ?ĐƌǇů ?ŝƐ ?
29:1 
1.5 
1.5 M Tris-HCl 
pH 8.8 (mL) 
3.8 3.8 0.5 M Tris-HCl 
pH 6.8 (mL) 
1.9 
10% (w/v) SDS 
(mL) 
1.5 1.5 10% (w/v) SDS 
(mL) 
0.75 
10% (w/v) APS 
(mL) 
0.15 0.15 10% (w/v) APS 
(mL) 
0.075 
TEMED (mL) 0.01 0.01 TEMED (mL) 0.01 
 
2.4.4.4. Solutions for two dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
2D lysis buffer:     Urea   600 g/L 
      CHAPS   20 g/L 
      DTT   10 g/L 
      Pharmalyte (pH 3-10) 20 mL/L 
 
Bromophenol blue stock solution  Bromophenol blue 100 mg 
      Trizma base  60 mg 
Made up to 10 mL with ddH2O 
 
Agarose sealing solution: 
1 x Laemmli SDS electrophoresis buffer     100 mL 
Agarose 0.5% (w/v)       0.5 g 
1% bromophenol blue stock solution     200 µL 
 
SDS equilibration buffer: 
Urea         360.5 g/L 
Tris-HCl, pH 8.8        50 mL/L 
Glycerol        344 mL/L 




SDS         20  g 
1% (w/v) Bromophenol blue      2 mL 
 
Fix solution:    Ethanol    300 mL 
     Acetic acid   100 mL 
Made up to 1 L with ddH2O 
 
2.4.4.5. Solutions for western blot analysis 
Transfer Buffer     Trizma base  25 mM 
      Glycine   200 mM 
      Methanol  20% (v/v) 
 
Phosphate buffered saline-PBS   NaCl   140 mM 
      KCl   3 mM 
      Na2HPO4  10 mM 
      K2HPO4   2 mM 
 
Tris-NaCl pH 7.5 wash buffer   NaCl   150 mM 
      Trizma base  50 mM 
The components were mixed and the pH was adjusted to pH 7.5 before adjusting to the final 
volume. 
 
2.4.4.6. Solutions for MALDI-TOF and MALDI-TOF-TOF 
Colloidal coomassie blue stain:   Ammonium sulphate 1.3 M 
      Methanol  34% (v/v) 
      Coomassie blue G250 1 g/L 
Matrix solution:     HCCA saturated in TA30 
 
2.4.5. Solutions for electron microscopy experiments 
Fixing solution     1% (v/v) glutaraldehyde in PBS 




Osmium tetroxide 2x stock   2% (w/v) in dH2O 
Uranyl acetate     5% (w/v) in dH2O 
Lead Citrate     0.1% (w/v) in dH2O 
 
2.4.6. Solutions for tetrapyrrole HPLC and HPLC-MS 
Solution A     Trifluoroacetic acid (v/v) 0.1% (v/v) 
Solution B     Acetonitrile   100% (v/v) 
All solutions were filtered prior to use. 
 
2.5. B12-analogue synthesis and purification 
 
2.5.1. Synthesis and purification of the upper ligand analog Texas-Red-B12 
 
Texas Red ?N-hydroxysuccinimidyl ester (Life Technologies, 0.026 mmol) was added to a 
slurry of ɴ-(3-aminopropyl) cobalamin (provided by Dr. Andrew Lawrence, 0.021 mmol), DMF 
(0.4 mL) and N,N-diisopropylethylamine (DIPEA) (0.05 mmol). The reaction was stirred for 
1.5 h, after which it was judged complete by HPLC analysis. MeOH (0.5 mL) was added to the 
reaction mixture and the solution was added to rapidly stirring 1:1 dichloromethane/diethyl 
ether (50 mL). The purple solid was triturated with 2×3 mL each of dichloromethane, 
acetone, and finally diethyl ether. The compound was dried in vacuo. Samples were resolved 
on an ACE 5AQ column (4.6 x 250 mm; Advanced Chromatography Technologies) attached 
to an Agilent 1100 series HPLC equipped with diode array. The column was developed with a 
binary gradient at a flow rate of 1.0 mL per min. The LC gradient corresponds to Section 2.8.5. 
Purified fractions were dried in vacuo and analysed by analytical LC-MS (Section 2.8.5) 
(Smeltzer et al., 2001). 
 
2.5.2. Synthesis and purification of lower loop B12 analogues 
 
2.5.2.1. Ethylene Diamine-B12 synthesis 
Solid 1,1`-carbonyldiimidazole (CDI, 260 mg) was added to cyanocobalamin (1.0 g, 
0.74 mmol) previously dissolved in dimethyl sulfoxide (12 mL) at 30°C, and the mixture 
stirred for 25 min. Ethylene Diamine (2.7 mmol) was added in one portion, and the mixture 
stirred for 24 h at room temperature. The mixture was poured into ethyl acetate (30 mL) and 
left to stand. The precipitate was filtered, and the red solid was washed with acetone. The 




product was dried in vacuo. The reaction mix was analysed by analytical LC-MS (Section 2.8.5) 
(McEwan et al., 1999). 
 
2.5.2.2. Synthesis of Oregon-Green-B12 and Bodipy-TR-X B12 
Oregon-Green or Bodipy-TR-X N-hydroxysuccinimidyl ester (Life Technologies, 0.026 mmol) 
were added to a slurry of Ethylene Diamine-B12 (Section 2.5.2.1), DMF (0.4 mL) and N,N-
diisopropylethylamine (DIPEA) (0.05 mmol). The reaction was stirred for 1.5 h, after which it 
was judged complete by HPLC analysis. MeOH (0.5 mL) was added to the reaction mixture 
and the solution was added to rapidly stirring 1:1 dichloromethane/diethyl ether (50 mL). 
The (orange or purple) solid was triturated with 2 x 3 mL each of dichloromethane, acetone, 
and finally diethyl ether. The products were dried in vacuo and the structure confirmed by 
analytical LC-MS (Section 2.8.5) (McEwan et al., 1999). 
 
2.5.2.3. Purification of Oregon-Green-B12 and Bodipy-TR-X B12 
Samples were resolved on an ACE 5AQ column (4.6 x 250 mm; Advanced Chromatography 
Technologies) attached to an Agilent 1100 series HPLC equipped with diode array. The 
column was developed with a binary gradient at a flow rate of 1.0 mL per min. Solvent A was 
0.1% (v/v) TFA and solvent B was acetonitrile. The column was equilibrated with 0% B. 
Following sample injection, the concentration of B was increased from 5 min to 20 min to 
40%, increased to 60% at 35 min and 100% at 45 min where it was held for 5 min before 
returning to starting conditions. The total length of each run was 60 min. Data were 
ƉƌŽĐĞƐƐĞĚƵƐŝŶŐŽŵƉĂƐƐ ?ĂƚĂŶĂůǇƐŝƐ  ?ƌƵŬĞƌ). Purified fractions were dried in vacuo. 
Purified samples were analysed by analytical LC-MS (Section 2.8.5). 
 




Unless stated otherwise medim and buffers were sterilised for 15 min at 121°C and 1 bar 
pressure in an autoclave. Temperature sensitive substances were filter sterilised (0.2 µm 
pore size). 
 
2.6.2. Storage of bacteria 
 
For long-term storage of bacteria, glycerol stocks were prepared. Glycerol was added to an 
overnight bacterial culture to a final concentration of 25% (v/v). The culture was then 
incubated on ice for 30 min before storage at -80°C. 





2.6.3. Plate cultures 
 
Bacteria were usually streaked directly from a glycerol stock onto agar plates and antibiotics 
or vitamin-B12 was added where required. The agar plates were incubated overnight at 37°C. 
 
2.6.4. Liquid cultures 
 
Liquid cultures were inoculated with a single colony from an agar plate culture. The medium 
ǁĂƐƐƵƉƉůĞŵĞŶƚĞĚǁŝƚŚĂŶƚŝďŝŽƚŝĐƐ ?>ŝƋƵŝĚĐƵůƚƵƌĞƐǁĞƌĞƐŚĂŬĞŶĂƚA? ? ? ? rpm in baffled flasks 
Ăƚ ? ? ? ?ĨƚĞƌŝŶĚƵĐƚŝŽŶĐƵůƚƵƌĞƐǁĞƌĞŝŶĐƵďĂƚĞĚĂƚ ? ? ?ĂƚA? ? ? ? rpm. 
 
2.6.5. Preparation of competent cells 
 
Competent E. coli cells were prepared based on a method previously described (Green; 
Sambrook, 2012). A bacterial overnight starter culture derived from a single colony was 
inoculated into 10 mL fresh LB broth and grown to an OD600 of 0.3. The cells were cooled on 
ice for 15 min and centrifuged at 850 x g at 4°C. The pellets were gently resusupended in 
25 mL of ice-cold 0.1 M CaCl2 and incubated on ice for 30 min. Cells were collected again by 
centrifugation and resuspended in 0.25 mL of 0.1 M CaCl2 containing 25% (v/v) glycerol. 




2.6.6. Transformation of E. coli competent cells 
 
Competent cells were defrosted on ice for 10 min before adding 0.5 µg plasmid DNA. The 
mixture was incubated on ice for 15 min and then heat-shocked by incubation at 42°C for 
50 sec before rapid transfer to ice and incubation for 2 min. After the addition of 250 µL LB 
medium, the cells were incubated at 37°C for 60 min to allow antibiotic resistance 
expression. The mixture was then spread on a LB agar plate containing the required 
antibiotics and incubated at 37°C overnight. 
 
2.6.7. Recombinant microcompartment/metabolosome production in E. coli 
 




The E. coli strains BL21 (DE3) and BL21 (DE3) pLysS were transformed with a vector containing 
the gene(s) of interest cloned in frame (Section 2.6.6). The recombinant strains (rBMC, A-T, 
A-U, mA-U and CFPA-U) was grown in 2YT (200 mL in baffled flasks) with ampicillin (and 
ĐŚůŽƌĂŵƉŚĞŶŝĐŽůĨŽƌƉ>ǇƐ^ƐƚƌĂŝŶ )Ăƚ ? ? ?ĂŶĚƐŚĂŬĞŶĂƚA? ? ?  rpm until the culture reached 
an OD600 of approximately 0.6. Protein production was induced with 0.1 µM IPTG overnight 
at 19°C. The cells were collected by centrifugation at 3,500 x g for 20 min at 4°C. The pellet 
was directly used for microcompartment and metabolosome purification (Section 2.6.11 and 
2.6.12). 
 
2.6.8. Culture of Citrobacter freundii ballerup 7851 
 
400 mL of NCE medium containing 10 mL 20% (v/v) succinate, 0.5% (v/v) 1,2-PD and 400 mM 
MgSO4 were inoculated with 2 mL overnight culture and incubated at 37°C, and shaken at 
A? ? ? ? ƌƉŵ ĨŽƌ  ?-9 h. The liquid culture was incubated overnight at 19°C at 160 rpm, after 
adding 0.5% (v/v) 1,2-PD. 
 
2.6.9. Lysis of cells using sonication 
 
Harvested cells were lysed by sonication using a Sonics Vibracell Unltrasonic processor, with 
an output wattage of between 20 and 30 in 30 sec bursts with 30 sec breaks repeated six 




2.6.10. Cobyric acid quantitative bioassay 
 
S. typhimurium (cysG and metE knock-out mutants, AR2680) was used as the indicator strain 
to estimate concentration of cobyric acid and later intermediates of various samples (Raux 
et al., 1996). A cysG mutation blocks the B12 pathway between uroporphyrinogen III and 
precorrin-2, but intermediates before cobyric acid cannot be taken up by Samonella. 
Therefore, the first intermediate, which can be detected, is cobyric acid. The bioassay plates 
containing the indicator strain were prepared as follows: bacterial growth was scraped from 
an overnight minimum medium plate containing methionine (50 mg/L) and cysteine 
(50 mg/L) [cysteine only for AR3612 due to the cysG mutation blocking the cysteine 
synthesis], washed three times with 0.9% (w/v) NaCl. The cells were finally mixed with 
300 mL of minimum medium agar previously cooled to 47/48°C. 10 µL sample droplets were 
placed on the surface of bioassay plates and the plates were incubated for 18 ŚĂƚ ? ?ȗ ?dŚĞ
extent of S. typhimurium mutant growth (in the bioassay plate agar) surrounding the sample 




application point is dependent upon the amount of cobyric acid present in the sample. 
Synthesised vitamin-B12-analogues were compared in equal concentrations to vitamin-B12 
(2 pmol). 
 
2.6.11. Purification of empty Pdu microcompartments 
 
Cells were harvested by centrifugation for 10 min at 4°C at 2683 x g (Lawrence et al., 2014). 
Wet cell pellets (1 g) were re-suspended in 10 mL Y-PER ? Plus (Pierce) supplemented with 
one tablet of Complete Protease Inhibitor Cocktail (Roche) and 1250 units Benzonase® 
nuclease (5 µL per 10 mL Y-PZ ?). The lysate was incubated for 3 h at room temperature and 
gently agitated (shaking platform). The lysate was pelleted for 5 min at 11,300 x g (Beckman 
Coulter, rotor JA 25.50, 4°C). The pellet was re-suspended in 2 mL 20 mM Tris-HCl, pH 8.0, 
20 mM NaCl. The suspension was centrifuged at 4°C for 5 min at 11,000 x g (Multispeed 
Refrigerated Centrifuge, ALC PK121R). The NaCl concentration of supernatant 2 was raised 
to 80 mM by addition of 5 M NaCl (24 µL of 5 M NaCl in 2 mL supernatant 2). Supernatant 2 
was then centrifuged at 4°C for 5 min at 11,000 x g. Pellet 3 (contained the 
microcompartments) was re-suspended in 1 mL of 20 mM Tris-HCl, pH 8.0 and clarified by 
centrifugation (4°C for 5 min at 11,000 x g). 
 
2.6.12. Purification of Pdu metabolosomes 
 
Cells were harvested by centrifugation and washed twice with 40 mL of buffer A. Cells (1 g 
wet weight) were resuspended in a mixture of 10 mL of buffer and 15 mL of B-PER-II, 25 mg 
of lysozyme, and 5 µL Benzonase (Sinha et al., 2012). The suspension was incubated at room 
temperature shaking at 60 rpm for 30 min. Cell debris was removed by centrifugation twice 
at 12,000 x g (Beckman Coulter, rotor JA 25.50, 4°C) for 5 min at 4°C, and BMCs were spun 
down at 20,000 x g for 20 min at 4°C. The pellet was washed once with a mixture of 4 mL of 
buffer A and 6 mL of B-PER-II, and then resuspended in 0.5 mL of buffer B. Remaining cell 
debris was removed by centrifugation at 12,000 x g for 5 min at 4°C and performed three 





2.7. Molecular Biology 
 




2.7.1. Electrophoresis of DNA 
 
DNA fragments were separated by agarose gel electrophoresis. 
 
2.7.2. Agarose gel 
 
The agarose gel percentage was chosen according to the size of the DNA fragments to be 
separated [0.7-1.5% (w/v) agarose in TAE buffer]. Routinely, a 1% (w/v) agarose gel was used. 
Agarose gels were set with the appropriate amount of agarose in 1 x TAE buffer with the 
addition of ethidium bromide to a final concentration of 0.5 µg mL-1. The DNA samples 
containing 20% (v/v) DNA loading buffer were loaded into the agarose gel wells and 
electrophoresis was carried out at 70 V for approximately 1 h using a SubCell GT 
electrophoresis tank (BioRad) connected to a Power PAC 300 power supply (BioRad). 
 
2.7.3. Visualisation of DNA 
 
Ethidium bromide is a fluorescent dye that intercalates between DNA base pairs. UV 
radiation (312 nm) is absorbed by the ethidium bromide and re-emitted at 590 nm in the red 
orange wavelength range. This allows visualisation of the DNA using a UV transilluminator. 
 
2.7.4. Isolation of plasmid DNA 
 
A QIAprep® Miniprep Kit (Qiagen) was used for the purification of plasmid DNA as described 
in the handbook according to the protocol for using a microcentrifuge. 
 
2.7.5. Restriction enzyme digest 
 
Plasmid DNA was digested using the relevant enzymes (10 U µL-1) and the optimal buffer 
chosen according to either the Promega or New England Biolabs information provided. The 
reactions were incubated for 2 h at the temperature required by the restriction enzyme 
before being subjected to electrophoresis. 
 
Table 2.5. Restriction enzyme digest 
Component Single digest Double digest 




dH2O 4 µL 4 µL 
Restriction enzyme 1 1 µL 0.5 µL 
Restriction enzyme 2 - 0.5 µL 
10x buffer 1 µL 1 µL 




2.8.1. Bradford protein assay 
 
The Bradford assay relies on the dye Coomassie brilliant blue G-250 binding to proteins, most 
readily to arginyl and aromatic residues, causing a shift in the absorbance maximum of the 
dye from the red cationic form (470-650 nm) to the blue anionic form (590-620 nm) in the 
presence of protein (Bradford, 1976). Therefore, the quantity of the protein can be estimated 
by measuring the amount of dye in the blue form at 595 nm. The protein assay dye from 
BioRad was added to diluted protein solution, and the reaction was carried out as described 
in the instructions. The reaction was left at room temperature for 10-30 min and the OD595 
was measured in duplicates. Simultaneously, a standard curve with bovine serum albumin (0, 
5, 10, 15, 20 and 25 mg mL-1) was generated. 
 
2.8.2. Polyacrylamide gel electrophoresis 
 
2.8.2.1. SDS-PAGE 
The composition of the gel, buffers and stain were previously described in Section 2.4.4.3. 
Polyacrylamide gels were run as previously described (Laemmli, 1970). The sample was 
denatured by 1:1 addition of SDS sample buffer and boiling for 5 min. Between 5 and 20 µL 
of denatured sample was loaded into each well and 5 to 10 µL molecular mass marker was 
run on each gel to estimate the relative molecular mass of the protein of interest and was 
performed at a constant voltage of 200 V using an Atta Dual Mini Slab AE6450 
electrophoresis apparatus and an Atto Mini Power electrophoresis power supply SJ1082 (GRI 
Ltd.). The gel was stained with coomassie blue stain or colloidal stain for MALDI MS-MS and 




2.8.2.2. Two dimensional polyacrylamide gel electrophoresis 




Purified microcompartment fractions were separated by two-dimensional (2D) denaturing 
electrophoresis that employed isoelectric focusing (IEF) and SDS-PAGE (Rasband, 1997). 
Purified microcompartment and metabolosome pellets were resuspended in 2D-PAGE lysis 
buffer. Protein concentration was quantified using Bradford assay and the sample 
ƐƚĂŶĚĂƌĚŝƐĞĚƚŽĐŽŶƚĂŝŶ ? ? ?ʅŐŽĨƉƌŽƚĞŝŶŝŶ ? ? ?ʅ>ĨŽƌ ?Đŵ/W' ?/ŵŵŽďŝůŝƐĞĚƉ,ŐƌĂĚŝĞŶƚ )
strips. Prior to running the first dimension, grains of bromophenol blue were added to the 
sample and subsequently the sample was applied to an IEF boat. The IEF dry strip (GE 
Healthcare pH 3-10 nonlinear 7 cm) was placed on top before being overlayed with 0.6 mL 
of mineral oil. The samples were then focused on a Pharmacia Biotech IPGphor IPG runner 
with the conditions stated in Table 2.6. 
 
Table 2.6. Isoelectric Focussing parameters 
IEF settings:    
Rehydrate 0 h at 20°C   
IEF Parameters 20°C  50 µA/strip 
S1 Step-n-hold   
 30 V  14 h 
S2 Gradient   
 200 V  0.45 h 
S3 Step-n-hold   
 500 V  0.45 h 
S4 Step-n-hold   
 1000 V  0.45 h 
S5 Gradient   
 8000 V  1.00 h 
S6 Step-n-hold   
 8000 V  9.00 h 
Stop    
S6 20°C 49  µA 1W 
4109 V  2934 Vhs  
Total: 8092 Vhr    
 
 
Following focussing, the strips were removed from the boats, rinsed with dH2O and placed in 
20 mL of SDS equilibration buffer containing 200 mg of DTT for 20 min. The strips were rinsed 
with dH2O followed by 20 mL of the equilibration buffer containing 500 mg of iodoacetamide. 
The strip was then placed onto a 15% SDS running gel, gaps sealed with the agarose sealing 
solution before running for 2 h at 180 V. The gel was then removed, fixed and stained with 
colloidal coomassie blue for analysis. Gel images were analysed in ImageJ v1.48 and protein 
spots picked for MALDI MS-MS (Section 2.8.5). 
 
2.8.3. Western blot analysis 
 




Proteins separated on a denaturing polyacrylamide gel (Sections 2.4.4.3 and 2.8.2) were 
transferred onto Hybond-P, hydrophobic polyvinylidene difluoride (PVDF) membrane from 
Amersham Biosciences (Towbin et al., 1979). The PVDF membrane was briefly soaked in 
100% (v/v) methanol before immersing in transfer buffer. The polyacrylamide gel, PVDF 
membrane, blotting paper and gauze pads were all soaked in transfer buffer for 10 min 
ďĞĨŽƌĞƚŚĞďůŽƚǁĂƐĐŽŶƐƚƌƵĐƚĞĚ ?dŚĞ ‘ƐĂŶĚǁŝĐŚ ?ǁĂƐƉůĂĐĞĚŝŶƚŚĞtĞƐƚĞƌŶůŽƚƚƌĂŶƐĨĞƌƚĂŶŬ
(BioRad) along with an ice block and filled with cold transfer buffer before being 
electrophoresed at 100 V for 75 min using a BioRad power pac 300. Once electrophoresis 
was complete the PVDF membrane was incubated with 5% (w/v) non-fat dry milk in PBS for 
at least 2 h to block non-specific sites before probing with antibodies. All solutions used for 
any Western blotting method used can be found in Section 2.4.4.5. To probe for His-tagged 
recombinant proteins, the His-tag monoclonal antibody (Ab) obtained from Novagen is used 
as the primary Ab. The epitope for this Ab are five consecutive histidine residues (HHHHH), 
and binding is not dependent on sequence context. The secondary Ab used is the goat anti-
mouse IgG alkaline phosphatase conjugate, also from Novagen. Once the membrane had 
been incubated in the 5% (w/v) milk solution in PBS, it was rinsed briefly three times with 
PBS and incubated for 1 to 2 hours at 4°C with the primary Ab at a working dilution of 1:1,000. 
After thoroughly rinsing the membrane three times with PBS and twice with Tris-NaCl wash 
buffer, the membrane was incubated with the secondary Ab for 1 h at room temperature at 
a working dilution of 1:5,000. The membrane was again washed thoroughly with Tris-NaCl 
ǁĂƐŚ ďƵĨĨĞƌ ďĞĨŽƌĞ ƉƌŽƚĞŝŶƐ ǁĞƌĞ ĚĞƚĞĐƚĞĚ ďǇ ŝŶĐƵďĂƚŝŶŐ ǁŝƚŚ ^ŝŐŵĂ &ĂƐƚ ? /W ?Ed
buffered substrate reagent, containing 0.15 mg/ml BCIP, 0.30 mg/ml NBT, 100 mM Tris 
buffer and 5 mM MgCl2. 
 
Alkaline Phosphatase + BCIP BCI AP   BCI + PO4, pH 9.5 
BCI + NBT  AP   insoluble, blue colour 
The colour was allowed to develop and the reaction stopped by immersing the membrane 
in water. The blots were stored dry. 
 
2.8.4. MALDI-TOF (MALDI MS) and MALDI TOF-TOF (MALDI MS-MS) 
 
2.8.4.1. Reduction and desalting 
To identify proteins, present within purified eBMCs, rBMCs and BMCs were subjected to SDS-
PAGE or 2D-PAGE. The gel was removed from the running buffer and fixed with a PAGE fix 
solution for 1 h. The gel was stained with colloidal coomassie stain and individual protein 
bands/spots were excised and prepared for MALDI-TOF and MALDI-TOF-TOF as follows. 
Bands of interest were excised with a clean scalpel, cut into small squares (1 x 1 mm) and 
transferred to a microfuge tube. The gel pieces were then washed with 100 µL of 50 mM 
NH4HCO3/acetonitrile (1:1) for 15 min and the spun down to remove the liquid. The gel pieces 
were shrunk by the addition of 100 µL acetonitrile and left to stand for 15 min. The samples 
were then spun down and the liquid was removed before incubation at 56°C for 30 min in 
50 µL of 10 mM DTT and 50 mM NH4HCO3. The gel pieces were centrifuged, the liquid 
removed and the samples shrunk briefly again in acetonitrile. The acetonitrile was 




subsequently removed and the samples incubated in 55 mM iodoacetamide and 50 mM 
NH4HCO3 for 20 min in the dark. Iodoacetamide solution was removed and gel pieces were 
washed twice for 15 min in 50 mM NH4HCO3. The gel pieces were then shrunk again in 
acetonitrile and acetonitrile removed and the samples dried in a vacuum centrifuge. 
 
2.8.4.2. In-gel digestion 
The gel pieces were rehydrated in 20 µL digestion buffer (10 mM NH4HCO3, 10% acetonitrile) 
containing 10 ng/µL of trypsin at 4°C (on ice). After 30 min, the supernatant was removed 
and 10 µL of digestion buffer without trypsin was added to keep gel pieces wet during 
enzyme cleavage. Samples were left at 37°C overnight. 
 
 
2.8.4.3. Extraction of peptides 
5 µL of acetonitrile was added to each sample before sonication in an ultrasonic bath for 
15 min. The supernatant was then removed and stored in a microfuge before the addition of 
10 µL of 50% (v/v) acetonitrile with 5% (v/v) formic acid and another sonication for 
15 minutes in an ultrasonic bath. The supernatant was removed and combined with the 
previous supernatant, and the samples were analysed by MALDI TOF and MALDI TOF-TOF on 
a Bruker Ultraflex machine.  
 
2.8.4.4. MALDI-TOF-TOF 
The sample (1 ʅ>ŽĨƚŚĞĂďŽǀĞƉĞƉƚŝĚĞĚŝŐĞƐƚ )ǁĂƐƉůĂĐĞĚŽŶƚŚĞƐĂŵƉůĞƚĂƌŐĞƚ ?ŶĐŚŽƌŚŝƉ
standard, 800 µm, Bruker) and dried (Alanen et al., 2014). 0.5 ʅ> ŽĨ ŵĂƚƌŝǆ solution was 
added and dried. The matrix was HCCA  ?ɲ-CHCA, 0.7 mgmL-1 in 85% (v/v) acetonitrile, 0.1% 
(v/v) TFA and 1 mM NH4H2PO4) (Sigma-Aldrich). For external calibration in the protein mass 
range, Peptide Calibration Standard I (Bruker) was used. MALDI TOF MS and MALDI TOF-TOF 
MS-MS analysis was performed in the positive ion mode using a Bruker UltrafleXtreme. The 
spectra were obtained in reflector mode with an acceleration voltage of 25 kV and a pulse 
ion extraction time of 80 ns. The mass range for MS was generally between 700 and 3500 
m/z. The number of laser shots summed in MS was 3500. The number of laser shots summed 
in MS-MS was 3000. The software FlexAnalysis (Bruker) was used for peak picking prior to 
using the standard Mascot search engine (Matrix Science Ltd). The peptide mass fingerprint 
was searched against the NCBI proteobacteria protein database. 
 
2.8.5. Analytical HPLC-MS 
 
For biological samples, protein was removed prior to analysis by HPLC-MS by heat (10 min at 
90°C), centrifugation at 13,000 x rpm and acidification to 0.1% (v/v) TFA. Samples were 
resolved on an ACE 5AQ column (2.1 x 150 mm; Advanced Chromatography Technologies) 
attached to an Agilent 1100 series HPLC equipped with diode array detector and coupled to 
a micrOTOF-Q mass spectrometer (Bruker). The column was developed with a binary 
gradient at a flow rate of 0.2 mL per min. Solvent A was 0.1% (v/v) TFA and solvent B was 




acetonitrile. For cobalamins and cobalamin derivatives the column was equilibrated with 0% 
B. Following sample injection, the concentration of B was increased from 5 min to 45 min to 
100%, where it was held for 10 min before returning to starting conditions. The total length 
of each run was 70 min. Data were ƉƌŽĐĞƐƐĞĚƵƐŝŶŐŽŵƉĂƐƐ ?ĂƚĂŶĂůǇƐŝƐ ?ƌƵŬĞƌ). 
 
2.9. Wide field fluorescence microscopy 
 
Fluorescently labelled bioengineered Pdu microcompartments (mCherryA-U, CFPA-U and 
YpetA-U) were purified as described in Section 2.6.11. Purified microcompartments (15 µL) 
were added on glass slides and 1 µL [1 mM] of B12 fluorophore (Texas-Red, Oregon Green or 
Bodipy-TR-X) was added before imaging. The samples were then visualised using an Olympus 
IX81 microscope with PlanApo 150x OTIRFM-SP 1.49 NA lens mounted on ASI stage (Applied 
Scientific), and illuminated using LED light sources (Cairn Research Ltd) with appropriate 
filters (Chroma). Samples were visualized using aPrinceton ProEM 1024 back-thinned EMCCD 
camera (Princeton Instruments), and the system was controlled with Metamorph software 
(Molecular Devices). Each 3D-maximum projection of volume data was calculated from 15 z-
plane images, each 0.2 ʅŵĂƉĂƌƚ ?ƵƐŝŶŐDĞƚĂŵŽƌƉŚŽƌƵƚŽƋƵĂŶƚyƐŽĨƚǁĂƌĞ ?&ŝŶĂůĨŝŐƵƌĞƐ
were generated using Adobe Photoshop software. 
 
2.10. Biophysical techniques 
 
2.10.1. Transmission electron microscopy (TEM) 
 
2.10.1.1. Dehydration and embedding 
A 200 mL culture of E. coli (BL21(DE3) pLysS) producing microcompartments of interest was 
grown overnight at 37°C. The cells (15 mL) were harvested by centrifugation and 
resuspended in fixing solution and left for 1 h. The cells were subsequently pelleted and fixing 
solution removed. Traces of the fixing solution were then removed by washing the cells twice 
with PBS. The samples were then resuspended in the primary stain, 1% (w/v) osmium 
tetroxide, and incubated at room temperature for 1 h. The samples were washed twice with 
PBS prior to dehydration. This was accomplished by subjecting the sample to a solvent 
gradient (Table 2.7). 
 
Table 2.7. Dehydration solvent gradient. 
Composition Solvent Time (minutes) 
70% Ethanol 20 
100% Ethanol 20 




100% Ethanol 30 
100% Propylene oxide 30 
100% Propylene oxide 30 
50:50 Embedding medium: 
propylene oxide 
60 
100% Embedding medium 180 
 
The embedding medium used was agar low viscosity resin. Components for a block of 
medium hardness are shown in Table 2.8. The samples were placed in 0.5 mL embedding 
tubes and centrifuged for 10 min at 4,000 x g to concentrate the cells to the tip, and 
incubated at 60°C overnight to polymerise. 
 
Table 2.8. Embedding medium components. 
Component Mass 
LV Resin 48.0 g 
VH1 Hardener 16.0 g 
VH2 Hardener 36 g 
LV Accelerator 2.5 g 
 
2.10.1.1. Sectioning and visualisation of samples 
Specimens were thin sectioned with a diamond knife on an RMC MT-6000-XL 
ultramicrotome. Sections were collected on copper grids and post-stained with 4.5% (w/v) 
uranyl acetate for 30 min at 60°C, and with 0.1% (v/v) and lead citrate for 10 min at room 
temperature. Sections were then visualised and photographed with a CEM 902 transmission 
electron microscope (Zeiss CEM 902). 
 
2.10.1.2. Sample preparation of purified microcompartments for transmission electron 
microscopy 
For EM analysis 15 ʅ>ŽĨƉƵƌŝĨŝĞĚŵŝĐƌŽĐŽŵƉĂƌƚŵĞŶƚƐǁĞƌĞŵŽƵŶƚĞĚŽŶƚŽ&ŽƌŵǀĂƌ ?ĐĂƌďŽŶ
coated 400 mesh copper grids for 2 min, followed by the addition of 15 ʅ>ŽĨ  ? ? ?A?  ?ǀ ?ǀ )
glutaraldehyde in PBS for 2 min. The grids were washed three times in 15 ʅ>ĚƌŽƉƐŽĨ ? ? ?A?
(v/v) glutaraldehyde in PBS and then three times in dH2O. Finally, the grids were dried and 
stained with 2% (w/v) aqueous uranyl acetate. Grids were analysed at zero-loss bright field 





2.10.2. Atomic force microscopy 
 
2.10.2.1. Sample preparation for AFM 




For semi-dry AFM, purified microcompartment samples were deposited onto freshly cleaved 
MICA surfaces for 5 min. Microcompartments were fixed using 2.5% (v/v) glutaraldehyde in 
PBS for 5 min. The surface was washed three times with 1 mL sterile filtered deionised H2O 
and dried under a gentle stream of N2 gas. Images were collected in air using Bruker 
Multimode 8 scanning probe microscope (Nano Inc.) and ScanAsyst air cantilever probes 
(Nano Inc.). 
 
2.10.2.2. High resolution imaging 
A nominal spring constant of 0.4 N/m was used. Height images of 4096 x 4096 pixels in size, 
covering surface areas of 10 x 10 µm to 20 x 20 µm were acquired at 20°C. Sample tilt and 
scanner bow were reduced using NanoScope1.40 (Nano Inc.) as described previously 
(Lawrence et al., 2014). Images were analysed using ImageJ 1.48v (Rasband, 1997) or 
NanoScope 1.40 (Bruker). Size distribution measurements of TEM and AFM images were 
conducted using ImageJ v1.48. Areas were measured in ImageJ v1.48. Diameters were 
calculated presuming microcompartments have circular shapes. Peak height information of 
125 single particles for each construct were obtained using NanoScope 1.40. Anova post hoc 
tests (Scheffe) were performed on all obtained data sets. 
 
2.10.2.3. Nano-mechanical measurements 
Deformation control experiment: spring constant and deflection sensitivity were estimated 
using a thermal tune procedure (for more information, see the user's guide of Nanoscope 
software 6.13). Tip geometry was estimated using an absolute method on a titanium 
roughness surface to scan the surface and Nanoscope 1.40 to qualify the tip geometry 
according to the image. 20 particles each were analysed on their change of height, reduced 
DMT modulus and deformation using NanoScope 1.40. 
 
2.10.2.4. In-solution AFM 
Samples were prepared on HOPG surfaces as described in Section 2.10.2.1 and rehydrated. 
Height images of 1024 x 1024 pixels in size, covering surface areas of 5 x 5 µm were acquired 






Chapter 3  
A proteomic comparison of wild type 
C. freundii Pdu BMCs to recombinant 
Pdu variants produced in E. coli 
 






The outer shell of BMCs is composed from a set of specific proteins that house a 
recognisable protein fold called a BMC domain (Sections 1.3.1 and 1.5.9) (Frank et al., 
2013). The BMC fold allows the proteins to oligomerise into hexameric tiles. Some 
proteins contain two BMC domains and those oligomerise into trimeric tiles with a 
pseudohexameric symmetry. Hexameric and pseudohexameric tiles are proposed to 
compose the facets of the BMC. 
In the Pdu metabolosome, hexameric tiles (pfam 00936) are thought to be formed by 
PduA, PduJ, PduK and PduU (Chowdhury et al., 2014). Pseudohexameric tiles are 
formed by PduB, PduB` and PduT (pfam 00936). A related, but distinct, BMC fold is 
also found in the pentameric shell protein, PduN (pfam 03319), which is thought to 
form the vertices of the BMC structure. Therefore, the shell protein composition 
plays a defining role in the assembly and properties of the organelle, affecting both 
the outward-facing surface of the assembly as well as the internal environment. 
Moreover, all shell protein tiles, whether hexameric, pentameric or trimeric, have 
distinct central pores that play a role in the semi-permeable nature of the outer shell. 
In this way, the composition of the shell also affects properties associated with 
diffusion into and out of the structure. 
Only one proteomic analysis of a catabolic metabolosome has been reported and that 
relates to the isolated Pdu metabolosomes from S. enterica. In that study the authors 
were able to purify intact Pdu metabolosome structures and the samples were 
subjected to 2D gel analysis followed by quantification in order to gauge the relative 
proportion of the proteins that make up the assembly. Interestingly, they found that 
with the S. enterica Pdu BMC PduB and PduB` constituted approximately a quarter 
(25%) of the total protein and more than half (52%) of the BMC shell. PduA and PduJ 
were also quite abundant and in this respect PduB, PduB`, PduJ and PduA constitute 
over 90% of the shell, which means that PduK, PduU and PduT are minor components 
(Table 3.1). The vertex protein, PduN, was not detected, poss




abundance. These results suggest that PduB, PduB`, PduJ and PduA play a major role 
in holding the overall structure together and in mediating the majority of movement 
into and out of the BMC. PduK, PduN, PduT and PduU are likely to play more 
specialised roles. 
 
Table 3.1. Shell protein composition based on Havemann and Bobik (2003). Percentage [%] and 
molecular masses of Salmonella BMC shell proteins as reported (*n.d. = not detected). 
Shell protein 
composition 
PduA PduB PduB` PduJ PduK PduN PduT PduU 
Molecular mass (kDa) 9.6 28.0 24.0 9.0 16.8 n.d.* 19.1 12.5 
% shell protein 16 27 25 23 3 n.d.* 3 3 
 
Following on from the proteomic study of the S. enterica Pdu BMC, researchers 
investigated the role of individual shell proteins through a programme of targeted 
gene knock-outs (Cheng et al., 2011). As predicted from the previous proteomic 
study, deletion of the major shell proteins such as PduB`, PduB and PduJ severeley 
impaired BMC formation (summarised in Table 3.2). Strangely, deletion of pduA did 
not prevent BMC formation, but its absence did result in propionaldehyde 
accumulation in the growth media and a growth arrest phenotype. 
 
Table 3.2. Essential structural proteins in Pdu metabolosomes and eBMCs. (+) essential structural 
component, expendable structural component (-).  
 PduA PduB PduB` PduJ PduK PduM PduN PduT PduU 
BMC - + + + - + + - - 
eBMC + + + + + - + - - 
 
In separate studies on the C. freundii Pdu system, it was shown that when the whole 
pdu operon was transformed into E. coli, the transformed bacteria were empowered 
with the ability not only to metabolise 1,2-PD, but also to generate recombinant BMC 




structures (rBMCs) (Parsons et al., 2008). The construction of these rBMCs effectively 
provided a powerful genetically tractable system with which to study BMC form and 
function. Following on from this research it was shown that empty BMCs (eBMCs) 
could be generated by the expression of selected shell protein genes (Parsons et al., 
2010a). The co-ordinated expression of the pduA-B-J-K-N (A-N construct) resulted in 
the appearance of proteinaceous bodies within the E. coli cytoplasm that had clear 
delimiting boundaries. Slightly larger structures were observed with the coordinated 
expression of pduA-B-J-K-N-U (A-U construct, Figure 3.1) and pduA-B-J-K-N-U-T (A-T 
construct). Smaller constructs containing pduA, pduA-B, pduA-B-J, pduA-B-J-K 
resulted in the appearance of filaments, swirls and rosettes within the cytoplasm of 
the cell. Thus, it would appear that eBMCs can be formed by a minimal set of shell 
proteins composed of PduA-B-J-K-N. 
 
 
Figure 3.1. Schematic illustration of empty microcompartments and Pdu metabolosomes. A. Features 
of empty microcompartments (A-T, A-U and mA-U) B. Features of 1,2-PD utilising microcompartments 
(rBMC and wild type). 
 
Furthermore, the order of gene expression would also appear important for BMC 
formation. Moving pduA to the end of the gene sequence, rather than having it at the 
start, was found to prevent BMC formation. In this respect, the relative abundance 




of certain shell proteins was found to prevent BMC formation. Thus, the shell protein 
composition appears to be instrumental in permitting the shell assembly of these 
remarkable structures. 
 
3.2. Aims and objectives 
 
Although the generation of a recombinant Pdu BMC has greatly assisted our 
understanding of BMC form and shape, no detailed comparison of wild type, 
recombinant Pdu BMCs or eBMC variants was conducted. The major focus of the 
research described in this chapter was to address this problem. Therefore, the 
presence of BMCs in wild-type C. freundii was investigated and methods for BMC 
extraction and purification were developed. This permitted a proteomic analysis of 
wild-type Pdu BMCs from C. freundii and their comparison to both rBMC and eBMC 
structures (A-U, mA-U and A-T) in E. coli. 
.  




3.3. Visualising Pdu microcomparment formation in vivo by electron microscopy 
 
As discussed earlier, the in vivo formation of bioengineered eBMCs and rBMCs in 
E. coli has been previously reported (Parsons et al., 2008; Parsons et al., 2010a; Sinha 
et al., 2012). The transformation of E. coli (BL21(DE3)) with the appropriate pdu genes 
results in the occurrence of cytoplasmic-located structures that appear to be 
consistent with the presence of BMCs as revealed by TEM after thin-sectioning of the 
cells. In this chapter, the presence of both rBMCs and a number of eBMC variants are 
compared to wild type C. freundii BMCs by TEM. 
A fully sequenced C. freundii ballerup strain (7851) with 99% sequence identity to the 
constructed pdu operon was obtained from the Sanger Institute (Cambridge, UK). To 
determine whether C. freundii had the ability to make Pdu BMCs, the strain was 
grown in NCE minimal medium in the presence of 1% (v/v) 1,2-PD (Section 2.6.4) to 
induce the formation of Pdu BMCs. After overnight growth the cells were harvested 
by centrifugation, resuspended in fixing solution, stained and embedded in agar low 
viscosity resin (in collaboration with Rokas Juodeikis, University of Kent). Cells were 
sectioned into 70 nm slices as described in Section 2.10.1. 
In parallel, a range of E. coli strains producing rBMCs and eBMCs were prepared. 
Three different eBMC variants were tested: A full set of BMC shell proteins (A-T), a 
reduced set missing PduT (A-U) and a variant with mCherry fused to PduA (mA-U) 
were compared to Pdu BMCs (wild type and rBMC). This comparison allows an 
opportunity to explore the effects of the missing BMC shell protein PduT and the 
mCherry-PduA fusion on BMC formation. E. coli (BL21DE3) was transformed with 
plasmids to allow the production of rBMCs and eBMCs (A-U, mA-U and A-T). The cells 
were grown in rich medium (2YT). After the cultures reached an OD600 of 0.3-0.6, the 
cultures were induced with 100 µM IPTG and were allowed to continue growing 
overnight (Section 2.6.4). Cells were harvested by centrifugation, resuspended in 
fixing solution, stained and embedded in agar low viscosity resin. Thin sections were 
placed onto carbon grids and stained with uranyl acetate and lead citrate as 
described in Section 2.10.1.  




Analysis of the thin sections by TEM provided clear results as shown in Figure 3.2. 
Firstly, as expected, thin sections of E. coli harbouring empty plasmids (Panels A and 
B) did not reveal the presence of any BMC-type of sub-cellular structure. Although 
the cytoplasm contains ribosomes and a nucleoid, no evidence of larger (100 nm) 
sized bodies are present within any of the observed bacteria. In contrast to control 
sections, a number of large proteinaceous bodies within the cytoplasm of the cell 
(Panel C) are clearly visible in C. freundii. Wild type Pdu BMCs appeared as distinct 
electron dense spots in the cytoplasm. Features such as size and shape appeared 
heterogenic. Although irregular in structure, wild type Pdu BMCs, had common 
features as distinct vertices and closed shells. Furthermore, they shared a pentameric 
to hexameric outline. Moreover, the bodies contain electron dense material 
suggesting high protein content. 
  





Figure 3.2. Presence of BMC in a range of bacterial strains. Left. Control section of E. coli containing 
pLysS and of E. coli containing pLysS and pET3a. Middle. Presence of BMC in a range of bacterial 
strains: Section of wild type C. freundii after growth on 1,2-PD. and section of E. coli containing the 
full recombinant pdu operon (rBMC) plasmid. Right. Section of E. coli containing the A-T, A-U and 
mA-U plasmid. Scale bars correspond to 200 nm. Single intracellular BMC structures are highlighted 
by arrows. 
 




Similar bodies, but in much greater abundance, have been observed in E. coli that 
house the complete pdu operon (Panel D). Interestingly, the E. coli appear to have 
more ribosomes (Figure 3.2), which could be due to cellular stress associated with 
recombinant protein production, or could be due to the fact that the ribosomes are 
compressed into a smaller area due to the abundance of rBMC structures (Hoffmann; 
Rinas, 2004). Both wild type and rBMCs are heterogeneous in size and structure, and 
appear to have pentameric or hexameric-like shapes. 
Cells containing the genetic material for eBMC variants (A-U, mA-U and A-T) were 
densely packed with closed proteinaceous subcellular structures. All the E. coli strains 
producing eBMCs were also found to contain similar irregular polygonal structures 
(Panels E-G) to wild type and rBMC structures (Panels C-D). The reduction of BMC 
shell proteins from A-T to A-U has no obvious detrimental phenotypical effect. The 
presence of the mCherry-PduA fusion producing mA-U strain (Panel F) does not 
appear to have an adverse effect on the size or shape of the empty organelle in 
comparison to the eBMCs produced in the strains harbouring A-U (Panel E) or A-T 
(Panel F). Overall, the size of the eBMCs was noticeably smaller than the rBMCs and 
wild type BMCs seen in C. freundii. These differences in size could be due to a 
difference in the BMC shell composition or could be due to the fact that eBMCs lack 
internalised proteins. The lack of incorporated enzymes could lead to a deflation of 
the overall structure. Finally, it is also noticeable that the size of the bacterial cells 
that contained the eBMCs varied. 
Many of the cells in Figure 3.2 appeared elongated, possibly due to problems 
associated with septation. Alternatively, elongated cells could reflect a stress 
response due to the pressure associated with producing so many unnatural 
structures within E. coli (Hoffmann; Rinas, 2004; Parsons et al., 2010a). The dense 
packing of the cells with eBMC variants and rBMC structures made it difficult to 
analyse single structures of eBMC variants and rBMCs. 
Due to the tight packing of recombinant Pdu microcompartments and the proximity 
of Pdu BMCs in wild-type Pdu BMCs, it was essential to extract and purify these 
structures as monodispersed particles. Purification permits the proteomic 




characterisation. Furthermore, the isolation of Pdu microcompartments is vital for 
structural analysis and the biochemical characterisation of cofactor uptake and 
accumulation. 
 
3.4. Development of purification strategies for eBMC variants, rBMC and wild type 
Pdu BMCs 
 
The detailed analysis of Pdu BMCs requires efficient and robust extraction and 
purification methods to allow the isolation of intact organelles in a sufficient yield for 
proteomic analysis, high resolution imaging techniques and biochemical 
investigations of the organelle. Two related methods have been independently 
developed for BMC isolation (Sinha et al., 2012; Lawrence et al., 2014). The two 
methods utilise mild detergent lysis procedures, employing either a bacterial specific 
lysis reagent (B-WZ ? )ŽƌĂǇĞĂƐƚƐƉĞĐŝĨŝĐ ůǇƐŝƐƌĞĂŐĞŶƚ  ?z-WZ ? ?^ĞĐƚŝŽŶ 2.6.11 and 
Section 2.6.12). The detergent based cell lysis method is a comparatively gentle 
method for releasing cellular contents without requiring more damaging as e.g. 
mechanical forces during sonication. To determine which purification works best, 
both processes were compared for the isolation of wild type BMCs, rBMCs and eBMC 
variants. The purified samples were analysed by SDS-PAGE (Figure 3.3). 
 
3.4.1. Evaluation of purification methods for rBMC and native BMC isolation 
 
Purified BMCs give a characteristic banding pattern that reflects the major proteins 
associated with the organelle in SDS-PAGE. This distinct fingerprint can be seen in 
Figure 3.3, lanes 2 and 4 (Sinha et al., 2012; Lawrence et al., 2014). In this case the 
two lanes represent wild type and rBMC purified by the B-WZ ?ƉƌŽĐĞĚƵƌĞ ?dŚĞƚǁŽ
lanes show that the rBMC and wild type BMCs have been purified to a high quality 




with the B-WZ ? ƉƌŽĐĞĚƵƌĞ. Major BMC shell protein bands at 30 kDa, 25 kDa, 
22 kDa, 10 kDa and 9 kDa represent PduB, PduB`, PduK, PduU, PduA and PduJ. 
Use of the Y-WZ ? ?>ĂŶĞƐ ?ĂŶĚ ? )ŵĞƚŚŽĚƌĞƐƵůƚĞĚŝŶƚŚĞŝƐŽůĂƚŝŽŶ ĨĂŶŝŶĚŝƐƚŝŶĐƚ
set of high molecular mass proteins. Analysis by SDS-PAGE revealed that BMCs were 
only purified effectively using the bacterial protein reagent (B-WZ ? )ƉƌŽƚŽĐŽů ?EŽ
differences in purification were observed for heterologously formed rBMCs and 
native microcompartments. For all follow up experiments BMCs (wild type and rBMC) 
were purified using B-WZ ? ? 
 
 
Figure 3.3. Comparative purification of BMCs using either B-WZ ? Žƌ z-WZ ? ƌĞĂŐĞŶƚ ?  ? ?A?
polyacrylamide gel, 10 µL loaded each lane, (M) marker. The typical shell protein fingerprint is shown 
on the right. 
 




3.4.2. Enhancing purification protocols for empty microcompartments by SDS-
PAGE 
 
Figure 3.3 reveals that all the eBMCs (A-U, mA-U and A-T) can be isolated to a high 
level of purity by using either the B-WZ ?Žƌz-WZ ?ŵĞƚŚŽĚ (Lanes 5 to 10).  
In summary, a comparison of the two major methods for BMC isolation reveals that 
the larger complete wild type and rBMCs should be purified by the B-WZ ?ŵĞƚŚŽĚ ?
The smaller eBMCs can be isolated by either method. The eBMC variants differ from 
BMCs in their purification, likely reflecting either a change in their shell protein 
composition or a change in their size. 
 
3.4.3. Evaluation of the purification protocols for the eBMC structures as judged 
by western blot analysis 
 
The two methods for BMC purification utilising either B-WZ ? Žƌ Y-WZ ? ƌĞĂŐĞŶƚ
were tested for their effectiveness in the purification of eBMCs. The purification of 
BMCs can become contaminated by the presence of aggregating proteins and thus 
proteins that are co-produced with BMCs can sometimes co-purify with purified BMC 
fraction. To evaluate the purification procedures the B-WZ ? ĂŶĚ z-WZ ?
purifications were performed in the presence and absence of eBMCs (A-U) in E. coli. 
After growth and cell lysis using either B-WZ ? Žƌ z-WZ ? and purification, co-
purification of either CobN or CobR was investigated by western blot using an anti 
His6 antibody (Section 2.8.3). The results, in Figure 3.4, suggest that the Y-WZ ?
method is more appropriate for the isolation of eBMCs as it restricts the amount of 
contamination from either CobN or CobR. In contrast, more signal is observed on the 
western when B-WZ ?ŝƐƵƐĞĚŝŶƚŚĞĞǆƚƌĂĐƚŝŽŶƉƌŽĐĞƐƐ ?dŚĞƌĞĨŽƌĞ ?ŝŶĂůůĨŽůůŽǁƵƉ
experiments the Y-WZ ?ŵĞƚŚŽĚƐǁĂƐused for eBMC isolation. 
 





Figure 3.4. Specificity of eBMC purification protocols in presence (+) and absence (-) of eBMCs judged 
by western blot analysis. The left blot demonstrates the relatively specific purification using Y-WZ ? ?
Western blot signal for CobN and CobR was only detected for crude lysate samples. The right blot 
demonstrates the relatively unspecific purification of CobN and CobR in Cl and final fraction (F), using 
the B-WZ ?ƉƵƌŝĨŝĐĂƚŝŽŶƉƌŽƚŽĐŽůŝŶďŽƚŚĂďƐĞŶĐĞ ?-eBMC) and presence (+eBMC) of eBMCs.  15% SDS-
PAGE. 10 µL loaded each lane. Cl and F were both applied to western blot analysis. Marker (M) is on 
the left and a positive control (+) on the right. 
 
3.5. Determination of the shell protein composition of Pdu microcompartments 
 
A proteomic analysis of wild type BMCs, rBMCs and eBMCs was undertaken to 
investigate significant differences in shell protein composition. As outlined above 
such changes in protein composition of the BMC shell and incorporated enzymes 
could alter their structure and potentially cause differences in their purification. To 
investigate their protein profiles, purified fractions containing BMCs were separated 
by 2D PAGE (Section 2.8.2). The 2D gels are shown in Figure 3.5. Protein spots were 
picked and analysed by peptide mass fingerprinting (MALDI TOF and TOF-TOF, 
Section 2.8.4, see appendix). 
 




3.5.1. Detection of single shell proteins of purified Pdu metabolosomes 
 
Pdu metabolosomes (rBMCs and wild-type) were extracted and purified from 
overnight cultures and analysed by isoelectric focussing and SDS-PAGE (2D-PAGE, 
Figure 3.5, Section 2.6.12 and 2.8.2). From the resulting gel, all encoded Pdu shell 
proteins in rBMCs produced in E. coli and wild type BMCs were identified (PduA, 
PduB, PduB`, PduJ, PduK, PduN, PduT and PduU). SDS-PAGE and 2D-PAGE suggest 
that the BMCs are purified to a high extent. 
All encoded shell proteins were identified from the purified Pdu microcompartment 
fractions. The high level of purity allowed the protein components of the BMCs to be 
quantified by densitometric measurements. 
 
3.5.2. Detection of single shell proteins of purified empty microcompartments 
 
The single shell proteins that were detected from the purified eBMC structures are 
shown in Figure 3.5. Details of the MALDI TOF-TOF analysis (Section 2.8.4) for 
individual shell proteins are reported in Section 7.1. The shell protein data are 
comparable to the previously reported proteomic study of the S. enterica Pdu BMC, 
as the shell proteins migrated with a similar profile. Predictably the data were also 
similar to Pdu BMCs from C. freundii formed natively or heterologously in E. coli 
(rBMC) (Havemann and Bobik, 2003; Sinha et al., 2012). 
 





Figure 3.5. 2D-PAGE of wild type BMC, rBMC and purified eBMC variants. Purified protein fractions 
(160 µg) were applied to 2D-PAGE. Molecular mass standards are shown on the left of each gel. Shell 
protein spots (red) and BMC related metabolic enzymes (green) were identified by tandem mass 
spectrometry. Wild type. Purified Pdu metabolosomes, extracted from C. freundii. rBMC. Purified Pdu 
metabolosomes, extracted from E. coli. A-T. Purified empty microcompartment (A-T), extracted from 
E. coli. A-U. Purified empty microcompartment (A-U), extracted from E. coli mA-U. Purified empty 
microcompartment (mA-U), extracted from E. coli. 




The 2D gels for the eBMC variants are shown in Figure 3.5. The gels reveal a clear 
separation of the various proteins. From these gels, the majority of the BMC 
associated proteins were identified by peptide mass fingerprinting. Protein spot 
localisation of eBMCs led to the identification of all BMC shell proteins. The purified 
eBMC fractions were estimated to be more than 90% pure by densitometric 
measurements of the SDS-PAGE (Figure 3.3) image. All eBMC variants were found to 
have a high degree of purification, suggesting that they had been isolated intact. 
 
3.5.3. Shell protein composition of Pdu microcompartments 
 
The protein spots observed in the 2D gels were quantified by densitometric 
measurements using ImageJ v.1.48 (Section 2.8.2.2; Figure 3.6) (Rasband, 1997). 




Figure 3.6. Shell protein composition of Pdu microcompartments. Normalised average abundance 
(N=3) of single shell proteins of Pdu metabolosomes (wild type and rBMC) and eBMCs (A-U, mA-U, A-
T) and standard errors of mean are given. The predominant shell protein is coloured green and the 2nd 
most abundant shell protein is coloured in orange. 
 
The results showing the relative abundance of the shell proteins in various BMCs are 
outlined in Figure 3.6. The most abundant BMC shell protein of the Pdu 
metabolosomes (rBMC and wild-type) is PduB` (28%, 31%). PduB (18%, 25%), PduA 




(23%, 19%) and PduJ (19%, 24%) are also major shell protein components. PduK, 
PduN, PduT and PduU are minor shell protein components comprising less than 10% 
of the shell. PduT was not quantified accurately due to its low spot intensity (see 
Figure 3.5-6). 
In the eBMC variants that were analysed, PduA was found to be the major Pdu shell 
protein component (27-35%) followed by PduB (18-24%). PduB` (12-16%) and PduJ 
(13-18%) are further major components of the Pdu shell. PduK, PduN, PduT (only in 
A-T) and PduU are the minor Pdu shell components comprising less than 20% of the 
Pdu shell. Although some variation in the shell protein composition has been noted 
for eBMCs, the overall trend is similar. 
The purified eBMC fractions differ from the purified BMC fractions in the relative 
abundance of their building blocks. Whereas PduA is the most abundant shell protein 
in purified eBMC fractions, PduB` is the most common BMC shell protein in purified 
Pdu BMC fractions of wild type and rBMCs. As with the analysis of the eBMCs, some 
variation was observed between rBMC and wild type BMC structures. In rBMCs the 
order of shell protein abundance is PduB`-PduB-PduA-PduJ whereas the wild type 
BMCs have an assigned hierarchy of PduB`-PduJ-PduA-PduB. However, overall the 
profile of the rBMC to wild type is remarkably similar indicating that they have a very 
similar composition. 
The major conclusion from this comparative proteomic analysis is that eBMCs appear 
to incorporate more PduA, in comparison to their Pdu counterparts (wild type and 
rBMC). Whether this reflects a different expression pattern or whether this reflects a 
consequence of lacking internal cargo has yet to be determined. 
  






The research in this chapter has addressed questions concerning the in vivo 
formation of heterologously formed eBMCs and rBMCs in E. coli and the wild-type 
assembly of Pdu metabolosomes in C. freundii. E. coli cells recombinantly producing 
eBMCs and rBMCs were found to be densely packed with supramolecular structures 
in comparison to the presence of fewer distinct organelles in wild-type C. freundii 
(Parsons et al., 2010a; Frank et al., 2013). 
The extraction and purification protocols for eBMCs and Pdu BMCs were compared 
in order to allow optimisation of the isolation procedures. Interestingly, eBMCs 
purified more effectively with Y-WZ ?ǁŚĞƌĞĂƐƌDƐĂŶĚǁŝůĚƚǇƉĞDƐƉƵƌŝĨŝĞĚ
more readily with B-WZ ? ?dŚĞĚŝĨĨĞƌĞŶĐĞƐŝŶƚŚĞƉƵƌŝĨŝĐĂƚŝŽŶůŝŬĞůǇƌĞĨůĞĐt differences 
in protein composition or other biophysical parameters. 
The protein composition of the eBMCs (A-U, mA-U and A-T) as well as the rBMC and 
wild type BMC were analysed by 2D-PAGE. This resulted in a series of well-resolved 
protein spots that allowed a detailed proteomic analysis of the organelles. In all cases 
the proteins were clearly identifiable, including the vertex protein PduN, whose 
presence has previously been difficult to identify due to its low abundance. 
The presence of the mCherry-PduA fusion did not affect the formation of the eBMC. 
This all helps to confirm the idea that the Pdu BMC assembly is a flexible process 
giving rise to highly stable macro-molecular structures. 
The quantification of the various shell proteins associated with BMC formation 
provided some interesting observations. With rBMCs and wild type BMCs, PduB is the 
most abundant shell protein. In contrast, with all eBMC variants PduA is the major 
shell protein. These differences in composition will be used to explain the differences 
in the physical properties of the eBMCs in comparison to the complete structures 
(see Chapter 4). The differences in protein composition may also explain 






Chapter 4  
A structural comparison (by AFM 
and TEM) of wild type C. freundii 
Pdu BMCs to recombinant Pdu 
variants produced in E. coli 







Following on from the proteomic differences observed in the shell protein 
composition of eBMCs and Pdu BMCs, the structural consequences of missing 
incorporated enzymes and altered shell protein composition were analysed. This was 
investigated by both EM and AFM, which, together, allow for estimations of the size 
distribution, nano-mechanical properties and the internal structural organisation of 
the organelles to be determined. 
Structural information of single Pdu BMC shell building blocks has been determined 
from X-ray studies of individual shell proteins such as PduA, PduB, PduT and PduU 
(Frank et al., 2013; Chowdhury et al., 2014). In addition to the structural information 
of various shell proteins of carboxysomes, the overall structure of extracted and 
ƉƵƌŝĨŝĞĚ ɲ-ĂŶĚ ɴ-carboxysomes has been reported in two independent studies 
through the use of electron cryo-tomography data (Schmid et al., 2006; Iancu et al., 
2007; Yeates et al., 2013; Rae et al., 2013). These studies revealed that tomographs 
of carboxysomes can be reconstructed as regular icosahedral structures, 
incorporating 20 faces, 30 edges and 12 vertices. In this model, all faces are 
triangular. The size distribution of carboxysomes was also reported. Surprisingly, this 
ƌĞǀĞĂůĞĚƚŚĂƚɲ-carboxysomes from H. neapolitanus varied between 90 and 100 nm, 
ǁŚĞƌĞĂƐɴ-carboxysomes from Synechococcus WH8102 had a size of 120 to 130 nm. 
More generally, carboxysome sizes range from 90 nm to more than 500 nm (Rae et 
al., 2013) ?ůƚŚŽƵŐŚƚŚĞƌĞĂƌĞŵĂŶǇƐƚƌƵĐƚƵƌĂůĂŶĚĨƵŶĐƚŝŽŶĂůƐŝŵŝůĂƌŝƚŝĞƐŽĨɲ-ĂŶĚɴ-
carboxysomes, it is not known if there are any functional consequences associated 
with the different sizes. In contrast to these relatively detailed structural analysis of 
the carboxysomes, much less is known about the size distribution, internal 
organisation and the overall structure of Pdu BMCs because isolated BMCs are much 
less homogeneous than their anabolic counterparts (Corchero; Cedano, 2011; Frank 
et al., 2013; Chowdhury et al., 2014). 




In fact, TEM analysis of catabolic Pdu BMC structures reveals that they are quite 
irregular in shape even though they have previously been described as regular 
icosahedral structures, analogous to carboxysomes (Corchero; Cedano, 2011). The 
diameter of the S. enterica Pdu BMC was reported as 123 ± 30 nm, indicating that 
they have a greater variation in size, in comparison to carboxysomes (Cheng et al., 
2011). Recombinant C. freundii Pdu BMCs (rBMCs) were reported to have a diameter 
of 108-123 nm but no structural data have been reported on the eBMCs or the wild 
type BMCs from C. freundii (Parsons et al., 2008). This chapter focuses on the 
structural characterisation of eBMC variants and their comparison to heterologously 
formed rBMCs and wild type BMCs. 
This was achieved by using a combinatorial approach consisting of different 
transmission electron microscopy (TEM) and atomic force microscopy (AFM) 
techniques to analyse the size distribution, nano-mechanical properties and internal 
structural organisation of C. freundii Pdu BMCs. The relative advantages and 
disadvantages of electron microscopy and atomic force microscopy are discussed 
below. Electron microscopes use accelerated electrons as a source of illumination 
(Adrian et al., 1984; Bai et al., 2015). The high resolution of electron microscopes 
relies on the, up to 105, shorter wavelength of electrons in comparison to light 
photons. Thus, smaller structures can be imaged with a resolution of up to 50 pm. 
Electrostatic and electromagnetic lenses are used to control the electron beam and 
focus it, to form an image, rather than the optical lenses found in light microscopy. 
In standard TEM applications, biological samples are chemically fixed by the 
crosslinking of proteins with aldehydes (standard TEM) or fixed by freezing in liquid 
ethane (for cryo-EM). Sample preparation requires negative stain (e.g. uranyl 
acetate). 
Atomic force microscopy (AFM) is a more recent technique that has evolved into a 
useful tool for the direct measurement of structural parameters. It can also be used 
to determine mechanical forces at a nanoscale level (Jalili; Laxminarayana, 2004). 
Typically, AFM systems consist of a micro-machined cantilever probe and a sharp tip 
(1-2 nm in diameter) mounted to a piezoelectric actuator and a position-sensitive 




photo detector for receiving a laser beam reflected off the end-point of the beam, to 
provide cantilever deflection feedback, as shown in Figure 4.1. 
 
 
Figure 4.1. Schematic of a basic AFM operation. 
 
The principle of AFM operations is to scan the tip over the sample surface. Feedback 
mechanisms enable the piezoelectric scanners to maintain the tip at a constant force 
or height above the sample surface. As the tip scans the surface, moving up and down 
with the contour of the surface, the differences in light intensities between the upper 
and lower photo detector are measured. The system is readjusted by a feedback loop 
corresponding to the incoming signal. 
Three operation modes are commonly used for AFM applications: non-contact mode, 
contact mode and tapping mode (Sweers et al., 2011; Foster, 2012). In this study, the 
ScanAsyst mode from Bruker was used for topological scans and high resolution 
imaging. Basically, ScanAsyst uses the tapping mechanism. In contrast to standard 
tapping mode imaging, critical imaging parameters are automatically adjusted. 
Automated feedback loops, such as ScanAsyst, ease the access for user groups not 
specialised on AFM applications and contribute to the implementation of AFM. 




The real advantage of AFM in comparison to other biophysical and structural tools 
lies in the possibility to directly measure topolopy and additional parameters in a 
simultaneous fashion. In compression studies (quantitative nano-mechanical 
mapping), nano-mechanical parameters (reduced Derjaguin-Muller-Toporov (DMT) 
modulus, adhesion, deformation and dissipation) of biological samples can be 
elucidated at the same time as requiring topological information. The Derjaguin-
Muller-Toporov (DMT) elasticity model describes the contact mechanics of the probe 
interacting with the scanned surface. In contrast to other elasticity models, the DMT 
modulus takes additional attractive interactions outside the area of contact into 
account. In less technical words, the reduced DMT modulus is used to describe the 
sample stiffness of the deposited biological sample. The cantilever impacts the 
surface only for a minimal amount of time to separate the contributions from 
different material properties such as reduced-DMT modulus and deformation. 
Quantitative nano-mechanical measurements (QNM) use the ability of the AFM 
system to acquire and analyse the individual force curves from each tap that occurs 








 Figure 4.2. Individual force curve for quantitative nano-mechanical measurements (© 
http://www.imaging-git.com). 
 
Thus, AFM can assist in the determination of nano-mechanical properties of 
biological materials. Further applications such as the measurement of particles in-
solution have helped establishing AFM as a powerful tool in the analysis of biological 
samples. 
 
4.2. Aims and Objectives 
 
In Chapter 3, methods for the isolation of intact Pdu microcompartments were 
developed, which permitted a comprehensive proteomic analysis. The purified BMCs 
provided an opportunity to investigate their structural and biophysical properties. 
The aims in this chapter are therefore to apply both TEM and AFM measurements to 
purified BMCs in order to compare their structural parameters. In this respect, 
purified wild type BMCs were compared to rBMCs and eBMCs.  




4.3. General observations of BMC imaging by TEM 
 
In parallel with the proteomic analysis of Pdu microcompartments (Chapter 3) the 
various microcompartments (wild type, rBMC, A-U, mA-U and A-T) were analysed by 
TEM (Section 2.10.1). To achieve this, isolated microcompartments were deposited 
onto carbon grids and were stabilised with glutaraldehyde. After washing, the sample 
grids were negatively stained with uranyl acetate and dried before visualisation by 
TEM. 
The isolated Pdu microcompartments (wild type, rBMC, A-U, mA-U, A-T) appeared to 
be highly pure as viewed by negative stain TEM (Figure 4.3). The TEM images are 
therefore consistent with the proteomic analysis in Chapter 3, which showed that the 
isolated compartments had a homogeneous protein content. As observed in 
Figure 4.3, some tendency for aggregation was seen for wild type BMCs (Panel A). 
This might be due to the high density of the wild type Pdu microcompartments or it 
may reflect on the ability of the structure to interact with other BMC particles. 
Wild type BMCs were also observed to adopt a wide variety of different shapes 
(Figure 4.3, Panel A) and appeared to be irregular in overall topology. No major 
differences in size and shape were visualised between wild type (Panel A) and rBMC 
structures (Panel B). This suggests that the heterologous formation of Pdu BMCs in 
E. coli does not affect BMC size. To identify significant differences between wild type 
Pdu BMC and rBMC structures or between different eBMC variants, the diameter and 
area of single particles (N>100) were measured by ImageJ v.1.48. These data are 
compared later on to those obtained by AFM in Section 4.5. 
No obvious structural differences were visualised between the different eBMC 
variants (Panels C-E). This suggests that the presence of PduT does not affect the BMC 
structure and that the fusion of mCherry to the N-terminus of PduA does not disrupt 
BMC assembly, size or shape.  




However, a clear size difference was visualised between 1,2-PD metabolising 
microcompartments (wild type and rBMC), when compared to eBMC variants. The 
differences in size (diameter and area) are quantified later in Section 4.5.  
 
 





Figure 4. 3. Representative TEM micrographs for purified Pdu microcompartments. A. Purified wild 
type BMCs, isolated from C. freundii after growth on 1,2-PD. B. Purified rBMCs, isolated from E. coli 
harbouring the full recombinant pdu operon plasmid (rBMC) C. Purified A-U eBMC, isolated from E. coli 
harbouring the empty shell construct A-U D. Purified mA-U eBMC, isolated from E. coli harbouring the 
empty shell construct mA-U. E. Purified A-T BMC, isolated from E. coli harbouring the empty shell 
construct A-T. Scale bars correspond to 100 nm. 




In addition to Pdu microcompartments, filamentous structures were visualised with 
the wild type and rBMC structures when imaged by TEM (Figure 4.4). The diameter 
of the filaments in the wild type Pdu BMC samples (10-20 nm) was smaller than the 
measured diameter in the rBMC samples (20-40 nm). On the other hand, filaments in 
wild type samples were observed to be longer (up to 10 µm) than those in the rBMC 
samples (<3 µm). These different characteristics (length and diameter) suggest that 
the filaments originate from different proteins. The protein(s) associated with these 
observed filaments was not identified. No filamentous structures were observed for 
the eBMC variants (A-U, mA-U and A-T) that were also imaged by TEM. 
 
 
Figure 4.4. Co-purified filamentous structures in TEM. Transmission electron microscopy (TEM) of 
filamentous structures in purified BMC fractions. Panel A. Purified wild type Pdu BMCs, extracted from 
C. freundii. Panel B. Purified recombinant Pdu BMCs (rBMC), isolated from E. coli. Scale bars 








4.4. General observations of BMC imaging in high resolution AFM 
 
One of the long term goals in the study of catabolic BMCs is to determine an overall 
structure of the organelle. One possible way to elucidate the structure of Pdu 
microcompartments is to use in-solution AFM. The advantage of in-solution 
measurements is that the sample is subject to comparatively mild sample reagents, 
which should retain the topology of the assembly. In contrast to EM, no harsh sample 
preparation steps such as freeze drying or staining are required. For in-solution AFM, 
(ideally) native samples can be imaged in a repetitive and non-invasive fashion. 
The sample preparation for in-solution AFM imaging is reported in Section 2.10.2.3. 
In contrast to high resolution semi-dry sample scanning (Section 2.10.2.2), purified 
Pdu microcompartments (wild type) were deposited onto a HOPG surface (graphene, 
no charge) for in-solution AFM and stabilised with glutaraldehyde. Unlike TEM 
sample preparation, AFM samples do not require staining. Next, the surface was 
washed with distilled water and dried under a gentle stream of nitrogen. Dried down 
surfaces were rehydrated in buffer and images were obtained using the ScanAsyst 
mode for in-solution applications. Areas of 5 µm x 5 µm were scanned at a resolution 








Figure 4.5. In solution AFM of rehydrated wild type Pdu BMCs. LEFT. Overview of a 3 x 3 µm crop out 
(autoscale setting). The white square resembles the single particle on the right. RIGHT. Single wild type 
Pdu BMC particle (top view, 240 x 240 nm). 
 
The initial experiment with purified wild type Pdu microcompartments provided 
several interesting insights. First of all, it was possible to image rehydrated BMCs at 
low resolution in a repetitive and non-invasive fashion. The second observation was 
that the size (diameter, area and height) of the deposited particles showed no 
difference to semi-dry AFM data shown in Section 4.4 and Section 4.5. However, in-
solution AFM did not improve the image quality in this study. Furthermore, technical 
difficulties did not allow the imaging of multiple sample specimens at a high 
resolution, as required for this study. Some sample drift was observed and thus 
technical solutions need to be found for this research to be taken forward. 
Consequently, this study focused on semi-dry AFM for the structural characterisation 
of Pdu microcompartments and their quantitative nano-mechanical measurements. 
In parallel with proteomic and negative stain TEM analysis, the various 
microcompartments (wild type, rBMC, A-U, mA-U and A-T) were scanned using semi-
dry AFM. The purified microcompartments were deposited onto MICA (silicate, 
negative charge) surfaces (Section 2.10.2.2). After deposition, BMC structures were 
stabilised by crosslinking with glutaraldehyde. The surfaces were washed with 
distilled water and dried under a gentle stream of nitrogen. Next, 10-20 µm squares 
were scanned at a resolution of 4096 samples per lane. Such high resolution 
measurements were conducted overnight to ensure run stability at a constant 
temperature. Both factors are necessary in order to generate stable, high quality 
scans (4½ h per scan). 
As with the TEM images of wild type and rBMCs, filamentous structures were 
observed. These filamentous structures found in wild type samples had lengths of up 
to 10 µm and an average diameter of 10-20 nm (Figure 4.6), whereas the filaments in 
the rBMC samples had a diameter of 20-40 nm and lengths of up to 3 µm. The 
measured peak height of both filamentous structures was roughly 10 nm. 






Figure 4.6. Co-purified filamentous structures in AFM. AFM scan of filamentous structures in purified 
BMC fractions. Panel A. Filamentous structures, extracted from C. freundii. Panel B. Filamentous 
structures, extracted from E. coli harbouring the rBMC plasmid. Scale bars correspond to 200 nm. 
 
After analysis of these filamentous structures, individual BMC particles were 
identified and characterised. The general observations made by AFM are consistent 
with those made by TEM reported in Section 4.3. All the isolated microcompartments 
(wild type, rBMC, A-U, mA-U and A-T) appeared to be highly pure. 
Catabolic Pdu BMC structures (wild type, Panel A; rBMC, Panel B) appeared 
heterogeneous in shape. No obvious size differences were observed between wild 
type and rBMC structures. However, the high resolution AFM scans of wild type and 
rBMCs revealed the presence of structures (Figure 4.7 and Figure 4.8), that appear to 
show budding. Such an event has been reported previously during ɴ-carboxysome 
biogenesis (Chen et al., 2013; Cameron et al., 2013). As described in Section 1.2, 
budding events are thought to play a major role in the biogenesis of BMCs. The 
biogenesis of carboxysomes was shown to be initiated by the nucleation of RuBisCO. 
The nucleate forms a procarboxysome. Next, BMC shell proteins surround the 
procarboxysome and cut off excess RuBisCO. The excess of nucleated RuBisCO, in 
proximity to the mature carboxysomes, acts as a nucleation zone for future 




carboxysome biogenesis (budding event). Such budding events are shown in 
Figure 4.8 (particle 2 of wild type and rBMC). More detail, which can be seen in 
Figure 4.7, shows a single rBMC particle undergoing a budding event. 
 
 
Figure 4.7. Budding event of a single rBMC structure in AFM. LEFT Top view of a single rBMC particle, 
270 x 270 nm (autoscale setting, top view). Right Side view of a single recombinant Pdu 
microcompartments (rBMC, 270 x 270 nm each) from left. 
 
Figure 4.7 shows a smaller, approximately hexameric, structure sitting on top of a 
mature rBMC. The observation of buds (wild type and rBMCs) suggest the purification 
of BMCs at different maturation stages. 
Next, eBMC structures were compared (Figure 4.8). All tested eBMC variants (A-U, 
Panel C; mA-U, Panel D; and A-T, Panel E) appeared irregular in shape and 
heterogeneous in size. Due to the variety in size and shape, it was difficult to 
determine structural differences between eBMC variants. Wild type and rBMCs 
appeared larger than the eBMC variants in negative stain TEM (Figure 4.3) and AFM 
(Figure 4.8). 
 










Figure 4.8. Topological AFM images of Pdu microcompartments. (LEFT) Overview of zoomed in 
4 x 4 µm height AFM scans (autoscale setting). White squares resemble crop outs for in-detail view. A. 
Purified Pdu metabolosomes (wild type), extracted from C. freundii. B. Purified Pdu metabolosomes 
(rBMC), extracted from E. coli. C. Purified empty microcompartments (A-U), extracted from E. coli. D. 
Purified empty microcompartments (mA-U), extracted from E. coli. E. Purified empty 
microcompartments (A-T), extracted from E. coli (RIGHT) In-detail height images of single Pdu 
microcompartments (240 x 240 nm each) from overview. 





To characterise and quantify differences between all the tested Pdu 
microcompartments, TEM images (Section 4.3) and AFM scans were used to measure 
single particles and quantify structural differences. 
 
4.5. Single particle analysis of Pdu microcompartments 
 
The size distribution of Pdu microcompartment structures is vital in order to 
understand nature`s design principles for BMC systems. The characterisation of size 
distribution by single particle analysis can assist the elucidation of driving forces for 
self-assembly. By using single particle analysis, differences between wild type 
C. freundii BMCs and the reported size of S. enterica BMCs can be compared. 
Likewise, wild type BMCs from C. freundii can be compared to rBMCs formed in 
E. coli. Similarly, the different eBMC variants (A-U, mA-U and A-T) can be compared 
in order to determine the effects of missing BMC building blocks and to analyse 
structural effects of the mCherry-PduA fusion on size distribution. 
The average diameter and area of TEM images and AFM scans were measured in 
ImageJ v.1.48 (Section 2.10). The peak height (AFM only) was measured in 
Nanoscope v1.40. More than a 100 single particles (individually for TEM and AFM) 
were measured for each tested BMC (wild type, rBMC, A-U, mA-U and A-T). 
Analysis of variance (ANOVA) was conducted by a single-step, multiple comparison 
procedure (Scheffe`s method, in collarboration with Wei-Feng Xue). No significant 
differences were found between the AFM and EM data sets for all Pdu 
microcompartments (wild type, rBMC, A-U, mA-U and A-T) that were analysed. 
From TEM and AFM data sets the diameter, area and peak height of Pdu BMCs (wild 
type and rBMC) were compared. The average diameter of C. freundii wild type Pdu 
BMCs was found to range from 94 to 175 nm (Figure 4.8). The isolated rBMC 
structures showed a slightly wider variability (72 to 201 nm) but the average values 




for diameters of Pdu metabolosomes (wild type and rBMC) were alike (122-131 nm). 
The average values of wild type BMCs and rBMC derived from C. freundii are 
consistent with the reported average diameter of the Pdu BMCs from S. enterica 
(123 ± 30 nm) (Cheng et al., 2011). 
To take the heterogeneous and irregular appearance of Pdu BMCs into account, the 
area, rather than diameter of wild type and rBMC particles was measured and 
compared. The area of individual wild type Pdu BMCs ranged from 0.008-0.016 µm2. 
Single particles of rBMCs were observed from 0.004-0.03 µm2. As with the average 
diameter, rBMC particles showed a higher variation in area size. The average area 
size of wild type and rBMCs (0.012-0.014 µm2) showed no statistical difference. 
In addition to 2D-parameters, peak height values from the AFM scans of wild type 
and rBMC particles permitted the 3D comparison of BMC particles (Figure 4.8). The 
peak height of individual Pdu microcompartments was smaller than the radius. This 
suggested that particle distortion may have occurred during sample deposition. 
Nonetheless, the peak height information still provided some new information 
concerning the size distribution of Pdu microcompartments. The peak height of wild 
type and rBMC particles ranged from 36 to 78 nm, with an average peak height of 49-
50 nm. As observed previously with both diameter and area, no significant 
differences were observed between wild type and rBMC structure (Figure 4.8). 
The determination of the average diameter, area and peak height of wild type Pdu 
BMCs and rBMC particles did not detect significant differences between them. 
Therefore, Pdu BMCs (wild type and rBMCs) are very similar and form one size cluster 
of Pdu microcompartments. These structural observations are consistent with the 
proteomic analysis in Section 3.5, which shows a high degree of similarity between 
wild type and rBMCs in terms of their protein composition.The slightly greater 
variation in diameter and area of rBMCs might be a consequence of differences 
between the host organism C. freundii and E. coli, or a consequence of making 
unnaturally large numbers of rBMCs in the cytoplasm (Section 3.3). The 
heterogeneity of Pdu BMC (wild type and rBMC) particles in diameter, area and 
height suggest the formation of irregular structures. 




In parallel with the analyses of wild type and rBMC structures, the eBMC variants (A-
U, mA-U and A-T) were also compared. The size distribution of eBMCs was quantified 
and reported in Figure 4.9. 
As with wild type BMCs and rBMCs, a wide variety of sizes were observed with all the 
eBMC variants (17-186 nm). Despite this variability, the eBMC variants had an 
average diameter between 40 and 80 nm. Importantly, no significant differences 
were observed for the average diameter values of A-U, mA-U and A-T. The average 
diameters of eBMC variants ranged between 56 and 77 nm. 
 
 
Figure 4.9. Single particle analysis of diameter, area and height of Pdu microcompartments. A. 
Diameter distribution of normalised data of TEM (blue) and AFM (red), bin of 10 nm. B. Area 
distribution of normalised TEM (blue) and AFM (red) data, bin of 0.001 µm2. B. Height distribution of 
normalised AFM data, bin of 5 nm red line.  
 
As with wild type and rBMC particles, the cross-sectional areas of all three tested 
eBMCs were compared (Figure 4.9). Interestingly, no significant differences in area 
size between A-U, mA-U and A-T were identified. The vast majority of all tested eBMC 
variants ranged between 0.001 and 0.006 µm2 and average values were obtained 
between 0.0025 µm2 and 0.0049 µm2. These differences were not significant. 




Finally the peak heights associated with the eBMC variants were compared 
(Figure 4.9). All eBMC variants appeared distorted, as their peak heights were smaller 
than their diameter. The peak height of the eBMC particles ranged from 12 to 37 nm. 
Average values of all three eBMC were alike with peak heights of 18-19 nm. 
The size distribution of all the eBMC variants revealed that they were all similar in 
terms of diameter, area and peak height. This study provides the first initial structural 
insights into the stability of eBMC assembly and allows several conclusions to be 
made. Firstly, reducing the set of building blocks from A-T to A-U had no structural 
consequences in size distribution. Secondly, the fusion of mCherry onto PduA had no 
effects on size distribution either. The size variation of eBMCs in terms of diameter, 
area and peak height may reflect the purification of eBMCs at different maturation 
stages, as it has been suggested for wild type and rBMCs. 
As mentioned in Sections 4.3 and 4.4, significant size differences were observed 
between Pdu BMCs (wild and rBMCs) and empty BMCs (A-U, mA-U and A-T). The 
average diameter of all tested eBMC variants was approximately half of that observed 
for wild type and rBMC particles. The average area of eBMC variants was 
approximately 1/3 of the average area of Pdu BMCs (wild type and rBMC). The 
average peak height of all eBMC variants was almost 40% of the average peak height 
of Pdu BMCs (wild type and rBMC). 
All eBMC variants formed smaller particles (average diameter, area and peak height) 
in comparison to Pdu BMCs (wild type BMCs). The structural differences could be a 
consequence of altered shell composition (described in Chapter 3) or a consequence 
of lacking internalised enzymes. To test this, the nano-mechanical stability of the 
eBMC variants was compared to the stability of wild type and rBMC structures. 
 
4.6. Classification of Pdu microcompartments by quantitative nano-mechanical 
mapping 
 




As well as recording 3D topographical measurements, AFM can also monitor further 
biophysical parameters, such as nano-mechanical properties of biological samples. 
Prior to such compression studies, it is vital to determine the deflection sensitivity 
and calibrate the spring constant using a thermal tune protocol of the probe and to 
measure the tip-radius using an absolute method (Section 2.10). 
The non-invasive manner of AFM for BMC peak height measurements was confirmed 
by compression studies at low forces (0.2-2.0 nN). In this control experiment, no 
difference in height were recorded (data not shown). Furthermore, no reduced 
Derjaguin-Muller-Toporov (DMT) modulus data, describing sample stiffness, were 
recorded. No deformation values were obtained for the Pdu microcompartment 
samples (wild type, rBMC, A-U, mA-U, A-T). This confirms that AFM is a non-invasive 
tool for the topological measurement of Pdu microcompartments. 
In a follow up experiment, the various Pdu microcompartment structures were 
subjected to force titration in order to identify the force ranges to allow for 
comparative compression studies. In this respect 250 nN was identified as sufficient 
force to measure the reduced DMT modulus and deformation. As with the single 
particle analysis in Section 4.5, wild type BMCs have been compared to rBMC 
particles and the eBMC variants (A-U, mA-U and A-T). For each particle class 20 
individual peak values of nano-mechanical properties (reduced DMT modulus and 
deformation) were measured in Nanoscope v.1.40 (Figure 4.10). 
The quantification of these two nano-mechanical properties gave some unexpected 
results. As shown in Figure 4.10, Pdu BMCs (rBMCs and wild type) showed a lower 
rigidity (5.0-5.4 Gpa), in comparison to the eBMC variants (A-U, mA-U and A-T). The 
reduced DMT modulus for eBMC structures ranged from 22.8-29.8 GPa. No 
significant differences were observed for Pdu BMC particles (wild type and rBMC) and 
eBMC variants (A-U, mA-U and A-T). On the other hand, significant differences were 
observed between Pdu BMC particles and eBMC variants. 
Figure 4.10 shows that the more elastic Pdu BMCs (according to DMT modulus) are 
more flexible to deformation (2.9-3.0 nm). In contrast, the stiffer eBMC variants only 
deformed 1.7-1.9 nm at an applied force of 250 nN. 




No significant differences in deformation were observed between wild type and 
rBMC particles. Thus, the recombinant production of BMCs does not appear to affect 
their size or properties. The same applies to eBMC variants. The fusion of mCherry to 
PduA (mA-U) and the presence of PduT (A-T) did not result in nano-mechanical 
changes in comparison to A-U. Significant differences were observed between the 
eBMC variants and complete Pdu BMCs. Quantitative nano-mechanical mapping 




Figure 4.10. Quantitative nano-mechanical mapping of Pdu microcompartments. Average values 
(N=20) and standard error of mean for reduced DMT modulus [GPa] and deformation [nm] are given. 
 
Topological and nano-mechanical information reveals that larger Pdu BMC structures 
(wild type and rBMC) are less stiff and more flexible than the eBMC variants. The 
proteomic shift from PduB`, in wild type and rBMCs, to PduA in the eBMC variants 
could be associated with the nano-mechanical stiffness and decrease deformation of 
the empty compartments (Section 3.5). Alternatively, the higher stability of eBMC 
structures could be caused by the specific or unspecific incorporation of cytoplasmic 
material in eBMCs. To test this, the internal structural organisation of Pdu 
microcompartments was investigated by using TEM to determine the presence of 
encased proteins by thin sectioning purified BMCs. 





4.7. Internal structural organisation and Pdu microcompartments 
 
4.7.1. The internal structural organisation of eBMC and BMC structures according 
to TEM  
 
Microcompartments were extracted from overnight cultures and purifed 
(Sections 2.6.7, 2.6.11 and 2.6.12). After precipitation, pellets containing mainly 
BMCs were fixed and embedded in low viscosity resin. Samples were thin sectioned 
and spotted onto carbon coated grids and visualised by TEM (Section 2.10.1). 
Wild type Pdu BMCs were compared to rBMCs (Figure 4.11). Both structures showed 
an intact outline with a pentameric or hexameric shape. Particles appeared 
heterogeneous, as described in Sections 4.3 and 4.4, and sampled diameter and area 
values corresponded to the analysis in Section 4.5 (data not shown). The lumen of 
wild type Pdu BMCs and rBMC appeared highly electron dense with granular spots. 
Such density would be consistent with the physiological role of Pdu 
microcompartments to sequester enzymes for 1,2-PD utilisation and reaction factors 
within an intact proteinaceous shell. No higher order was observed for the internal 
structural organisation of wild type and rBMC structures in negative stain TEM. 
The eBMC variants (A-U, mA-U and A-T) showed intact outlines that appeared 
heterogeneous in size and shape as observed previously in Sections 4.3 and 4.4. 
Diameter and area values of single eBMC structures as thin sections of wild type and 
rBMCs were consistent with reports in Section 4.5. In contrast to the wild type and 
rBMCs, all eBMC variants showed low electron density in the lumen. This suggests 
that eBMCs form hollow structures. The formation of intact and hollow structures is 
not affected by the presence of PduT or mCherry fused to PduA. These observations 
support the hypothesis that eBMCs form intact but hollow structures. 
 










Figure 4.11. Electron microscopy images of sectioned and purified Pdu microcompartments. Section 
thickness of 70 nm. LEFT Overview of thin sectioned Pdu microcompartments. RIGHT In-detail view of 
thin sectioned Pdu microcompartments. Panel A. Purified wild type Pdu BMCs, extracted from 
C. freundii. Panel B. Purified rBMCs, extracted from E. coli. Panel C. Purified A-U eBMC, extracted from 
E. coli. Panel D. Purified mA-U eBMC, extracted from E. coli. Panel E. Purified A-T eBMC, extracted 
from E. coli. Scale bars correspond to 100 nm. 





4.7.2. The intact and hollow structure of a eBMC in cryo-tomography 
 
The structural analysis of Pdu microcompartments was investigated further using 
cryo electron-tomography (in collaboration with Dr. Lorna Hodgson and BSc. Judith 
Mantell, University of Bristol). Cryo-tomography imaging allows the 2D data 
acquisition of freeze dried Pdu microcompartments, by rotation of the electron beam 
(Figure 4.12). 2D images can then be reconstructed to a 3D model. 
In cryo-tomography, A-U particles showed an intact outline with pentameric to 
hexameric symmetry. The particle sizes are consistent with the diameters and areas 
reported by negative stain TEM in Section 4.3 and 4.5. The eBMC (A-U) appears 
hollow in cryo electron-tomography. This provides further evidence that the A-U 
eBMC represents an empty protein capsid and shows the potential of cryo-
tomography to study the overall structure of BMC structures in general (Bai et al., 
2015). 
 





Figure 4.12. Intact and hollow structure of one eBMC variant in cryo electron microscopy. Structures 
of eBMCs (A-U) are highlighted by arrows. Black dots correspond to gold particles for tracing during 
z-series. 
  






In the previous chapter proteomic differences between wild type, rBMCs and the 
eBMC variants were identified. This chapter focussed on the biophysical 
characterisation of size, nano-mechanical properties and internal structural 
organisation of the various compartments. Different EM and AFM techniques have 
been employed to investigate the nature and biophysical properties of Pdu 
microcompartments. In contrast to the structure of the anabolic carboxysomes, Pdu 
BMCs appear irregular in size and shape. Differences in size and nano-mechanical 
properties between wild type and rBMC particles and the tested eBMC variants were 
quantified. From these studies it can be concluded that eBMCs are hollow, more rigid 
and less flexible than the more densely packed wild type and rBMC particles. 
In addition to the characterisation of the Pdu microcompartment particles, 
filamentous structures were co-purified with both wild type and rBMCs. Two Pdu 
related proteins are reported to form filamentous structures, PduA which can self-
assemble into nano-tubular structures and PduV which is thought to have a role in 
filament-coordinated metabolosome movement in the cell (Frank et al., 2013; 
Chowdhury et al., 2014). However, the protein identity of the observed filamentous 
structures has yet to be assigned. 
The observation of budding events requires further experimental back-up. The 
observation of buds on Pdu BMCs still represents an important development in the 
characterisation of Pdu BMCs. Budding of BMCs is thought to be a consequence of 
the BMC shell surrounding its cargo (Section 1.2). The observation of budding events 
suggests that Pdu BMCs pinch off excess cargo material. The excess material acts as 
a nucleus for the biogenesis of further BMCs (Chen et al., 2013; Cameron et al., 2013). 
However, eBMCs are capable of forming in the absence of any cargo and no buds 
were observed for eBMCs. Further information on the frequency of buds and the 
timing of their appearance will provide greater insight into the maturation process 
associated with BMCs. 




Interestingly, no size differences were observed between wild type particles from 
C. freundii and those from S. enterica (Cheng et al., 2011). Likewise, the heterologous 
formation of Pdu BMCs from C. freundii in E. coli (rBMCs) had no effects on the 
average particle size, nano-mechanical properties and internal structural 
organisation. 
Similarly, no structural differences in size were identified for the eBMC variants. A full 
set of Pdu shell proteins (A-T) was compared to a reduced set of building blocks (A-
U) and labelled building blocks (mA-U). All of them were shown to form particles of 
the same general size, quantitative nano-mechanical properties and internal 
structural organisation. Biophysical similar structures with regard to eBMC variants 
and Pdu BMCs (wild type and rBMC) further establish the idea that BMC shell 
formation is a stable and flexible process. 
Despite the similarities between eBMC variants and Pdu BMCs (wild type and rBMC), 
significant differences were observed in size, quantitative nano-mechanical 
properties and internal structural organisation (Section 4.3-7). The Pdu BMCs (wild 
type and rBMCs) are about twice the size of the empty variants. Moreover, they are 
less stiff and more compressible than the smaller eBMCs. 
These physical properties could reflect differences in the shell protein composition 
where PduB and PduB` are the most abundant BMC shell protein in wild type and 
rBMC structures, whilst the major BMC shell proteins in all the eBMC variants is PduA. 
But, it is not understood if differences in shell protein composition or the missing 
internal protein scaffold cause the observed biophysical differences between Pdu 







Investigations into the uptake and accumulation of 
cobalamin in a bacterial microcompartment






The previous Chapters, 3 and 4, focussed on the proteomic and biophysical 
characterisation of wild type BMCs, rBMCs and eBMC (A-U). The research objective 
of this chapter was to investigate a functional aspect of the BMC. In particular, it aims 
to characterise cobalamin uptake by the BMC and whether the BMC variants have an 
effect on the process. 
Adenosylcobalamin (Ado-B12) is an organometallic (Co) cofactor (Figure 5.1) that 
contains a modified tetrapyrrole macrocycle, which is closely related to other 
pigments of life such as haem (Fe), chlorophyll (Mg) and the lesser known coenzyme 
F430 (Ni) (Raux et al., 2000; Banerjee; Ragsdale, 2003). Cobalamins are composed of 
three core structural components: (I) A corrin ring, (II) a lower nucleotide loop and 
(III) an upper ligand. The corrin ring donates four ligands to the central cobalt ion. The 
ůŽǁĞƌ ?ɲ )ůŝŐĂŶĚŝƐƵƐƵĂůůǇĚŽŶĂƚĞĚďǇ ? ? ?-dimethyldbenzimidazole (DMB), which is 
within the nucleotide loop. The ƵƉƉĞƌ ?ɴ )ůŝŐĂŶĚŝƐƚŚĞƐŝǆƚŚďŝŶĚŝŶŐƉĂƌƚŶĞƌĨŽƌƚŚĞ
central cobalt ion and plays a key role in the biological activity of the molecule. 
Methylcobalamin (Me-B12) and adenosylcobalamin (Ado-B12) represent the two 
major biological forms of cobalamin. Hydroxycobalamin (OH-B12) and the artificial 
cyanocobalamin, better known as vitamin-B12, represent inactive forms of cobalamin. 
Inactive forms of cobalamin can be assimilated (vitamin-B12) or reactivated (OH-B12) 
to Ado-B12. More recently, cobalamin, with no upper ligand, has been shown to be 
the active form in reductive dehalogenases (Payne et al., 2014). 
 





Figure 5.1. ŽďĂůĂŵŝŶƐƚƌƵĐƚƵƌĞ ?ŽďĂůĂŵŝŶƐĂƌĞĚŝƐƚŝŶŐƵŝƐŚĞĚďǇƚŚĞŝƌɴ-ligand (red), corrin ring 
 ?ďůƵĞ )ĂŶĚɲ-ligand (yellow). 
 
A number of BMCs house cobalamin-dependent processes. Both the Pdu and Eut 
BMCs contain Ado-B12 enzymes in the form of propanediol dehydratases (PduCDE) 
and ethanolamine ammonia lyase (EutBC), respectively (Havemann; Bobik, 2003; 
Mori et al., 2004; Chowdhury et al., 2014). Both BMCs also house a set of Ado-B12 
reactivation factors for cobalamin assimilation and reactivation. The reactivation 
enzymes (PduGH, PduO and PduS) have been suggested to increase the availability 
of Ado-B12 in spatial proximity to the Ado-B12-dependent propanediol dehydratase 
(PduCDE). The Ado-B12 dependent degradation of 1,2-PD and Ado-B12 reactivation are 
described in Section 1.5.2. However, it is not known how cobalamin enters the BMC, 
although EutL would appear to be able to bind to cobalamin in the Eut metabolosome 
(Thompson et al., 2014). The crystal structure of EutL from Clostridium perfringens is 
a homolog to PduB (PDB code: 4U6I) and was reported to bind cobalamin in the 
crystal structure. Intriguingly, the binding amino acid residue His32 is not conserved 
along EutL homologs and therefore the biological relevance of this study is 
questionable.  




5.2. Aims and Objectives 
 
The interaction of Pdu organelles with the cellular cobalamin pool requires the 
attachment of cobalamin to the shell or its encasement within the metabolosome 
but no experimental evidence has been provided as to how this might occur. In this 
chapter, the ability of BMCs, both in vivo and in vitro, to associate and potentially 
accumulate cobalamin is investigated, in order to provide the first firm evidence for 
a cobalamin accumulation process. 
  




5.3. Association of soluble cobalamins with Pdu microcompartments in vitro 
 
An in vitro approach was applied to check for the association of different cobalamins 
with Pdu microcompartment structures rather than the individual shell proteins. 
Strains producing wild type BMCs, rBMCs and eBMCs (A-U) were grown overnight to 
allow the production of the intracellular macromolecular structure. 
After cell lysis using B-WZ ? ?^ĞĐƚŝŽŶ 2.6.12) and Y-WZ ? ?^ĞĐƚŝŽŶ 2.6.11) and the first 
centrifugation step, cobalamin (2 µM, Ado-B12, Me-B12, OH-B12 and vitamin-B12) was 
added to the BMC containing solution and equilibrated at 4°C. After 30 min, the Pdu 
microcompartments (wild type, rBMC and eBMC) were purified. 
The cobalamin content of the purified Pdu microcompartments was compared to the 
initial cobalamin content by LC-MS, as reported in Figure 5.2. 
 





Figure 5.2. Co-precipitation of different cobalamins with Pdu microcompartments (eBMC, rBMC and 
wild type). The figure shows the extracted ion chromatograms of co-precipitated cobalamins. Labelled 
peaks correspond to different cobalamins (Ado-B12, Me-B12, OH-B12 and vitamin-B12) that purified with 
wild type, rBMC and eBMC, purified fraction (F, green) and initial concentration (Pre, red). Extra peaks 
on the chromatogram likely correspond to sample impurities not related to cobalamin according to 
retention time and UV-Vis. 
 
According to the retention time and the extracted ion chromatogram in Figure 5.2, 
wild type and rBMC structures co-precipitated with all tested cobalamins. The 
association of cobalamins with wild type and rBMC structures suggests an ability of 
the organelle to associate with cobalamins. 




Similarly, according to the retention time and the extracted ion chromatograms of 
the eBMC structures, Ado-B12, Me-B12, OH-B12 and vitamin-B12 were all found to 
associate with this empty microcompartment structure. 
The co-purification of cobalamins with the Pdu BMCs (wild type, rBMC and eBMC) 
was not due to the use of different protocols as both the B-WZ ? ĂŶĚ z-WZ ?
protocols were employed. Similarly, the association of cobalamin was not dependent 
on the presence of internalised Ado-B12 dependent enzymes and reactivation factors. 
Instead, the association of cobalamins with the tested BMC structures (wild type, 
rBMC and eBMC) suggests an inherent ability of the BMC shell itself to bind 
cobalamins. To investigate this further, an in vivo system was developed to study the 
intracellular cobalamin pool in the presence of Pdu microcompartments. 
 
5.4. Growth in minimal media results in enhanced uptake of vitamin-B12 in 
C. freundii 
 
Detecting cobalamin is often limited by the low levels that are found associated in 
biological samples. LC-MS, for instance, has a detection limit of around 0.1 µM. 
Utilising biological systems that can accumulate cobalamin above this level are 
therefore desirable. In this section methods were applied that allowed for cells to 
accumulate more cobalamin.  
Initially, both E. coli and C. freundii were grown in minimal medium (NCE) that 
contained 1 µM exogenous vitamin-B12 (Section 2.4.1 and Section 2.6.8). As shown in 
Figure 5.3, the E. coli cell pellet displayed no coloration that would indicate high 
cobalamin uptake. 
 





Figure 5.3. Evidence of increased cobalamin uptake in C. freundii when grown in minimal medium. 
 
In contrast, the cell pellet of C. freundii grown in minimal medium was strongly 
orange / red coloured. The coloration of the pellet suggested uptake of vitamin-B12. 
The presence of cobalamin was confirmed by LC-MS (Section 5.7 and 5.9). The 
differences in medium culture between C. freundii and E. coli, which are closely 
related phylogenetically, were not further investigated. Instead, methods were 
developed to improve cobalamin-uptake in E. coli, in order to allow a more direct 
comparison of recombinant Pdu microcompartment systems (rBMC and eBMC) to 
wild type. 
 
5.5. Deregulation of vitamin-B12 uptake in E. coli by homologous overproduction 
of BtuB 
 
Cobalamin-uptake in Enterobacteriaceae is regulated through a riboswitch control 
element of the outer membrane tranporter gene btuB (Gallo et al., 2008). Dr. Evelyne 
Deery deregulated cobalamin uptake by the homologous overproduction of BtuB in 
E. coli (BL21(DE3), Figure 5.4, unpublished data). As observed with C. freundii grown 
in minimal medium, cell pellets of E. coli overproducing BtuB showed a strong 
coloration when fed with 1.0 µM vitamin-B12 in contrast to control samples. The 
presence of intracellular cobalamin was confirmed by LC-MS in Sections 5.7 and 5.9. 
 





Figure 5.4. Deregulation of cobalamin uptake in E. coli by homologous overproduction of the outer 
membrane transporter protein BtuB. Uptake was compared to C. freundii grown in NCE minimal 
medium. 
 
The increased uptake of cobalamin established an in vivo system to study the 
intracellular cobalamin pool of wild type C. freundii forming native BMCs and in E. coli 
forming rBMC and eBMC structures. 
 
5.6. Effect of Pdu microcompartments on cobalamin uptake into the cell 
 
Control strains (C. freundii (-1,2-PD) and E. coli (+BtuB)) and strains producing wild 
type Pdu BMCs (C. freundii (+1,2-PD)), rBMCs and eBMCs (A-U) were grown 
overnight, in the presence of low concentrations of vitamin-B12 [0.1 µM]. The cells 
were harvested by centrifugation. The cell pellet was washed twice with buffer A 
(Section 2.8.5 and Section 2.6.12) to separate extracellular cobalamin from the cell 
pellet. The cell pellet was resuspended in buffer A and lysed by heat (10 min at 95°C). 
Cell debris was pelleted by centrifugation (10 min at 13,000 rpm). The supernatant 
was acidified with TFA to a final concentration of 0.1% (v/v). Protein was pelleted by 
centrifugation. The final supernatant was analysed by LC-MS. 




Analysis of the lysate of C. freundii grown in minimum medium and in the absence of 
1,2-PD i.e. in the abscence of BMCs, resulted in the accumulation of Ado-B12. This 
indicates that C. freundii has a good cobalamin uptake system and that it is able to 
convert cyanocobalamin efficiently into the coenzyme form. Similarly, deregulated 
E. coli, which do not produce BMCs, also efficiently accumulated vitamin-B12 and 
converted it into Ado-B12. 
In contrast to C. freundii and E. coli control strains that accumulated Ado-B12 in the 
absence of BMCs, both organisms accumulated vitamin-B12, as the major form of 
cobalamin in the presence of the organelle. With C. freundii grown on 1,2-PD, 
vitamin-B12 was the major form although significant levels of OH-B12 were also 
observed. No Ado-B12 was detected. The accumulation of vitamin-B12 was more 
prominent in the E. coli strains producing rBMCs and eBMCs. These results were not 
expected as the BMC would be expected to accumulate Ado-B12, which is the 
coenzyme form required by the diol dehydratase. In addition, fully functional BMCs 
contain reactivation factors, such as PduS and PduO, to help produce Ado-B12 
(Section 1.5.3). It may be that vitamin-B12 is accumulated within the BMC, prior to the 
action of the cytoplasmic enzyme systems that are able to convert it into Ado-B12. 
However, once in the BMC the organelle does not contain an effective decyanase to 
help remove the upper cyano ligand. Hence, vitamin-B12 accumulates within the 
BMC. 
 





Figure 5.5. Pdu microcompartments alter the intracellular cobalamin pool. Extracted ion 
chromatogram of control samples without Pdu microcompartments from C. freundii (-1,2-PD, -BMC) 
and E. coli (+BtuB), C. freundii forming Pdu BMCs (+1,2-PD, +BMC) and E. coli forming rBMC (+BtuB, + 
rBMC) and eBMC (+BtuB, +eBMC) structures in presence of 0.1 µM vitamin-B12 in the growth medium. 








5.7. Sub-cellular cobalamin pool in purified Pdu microcompartments 
 
The previous section (5.7) revealed that cells that contain BMCs are able to 
accumulate exogenously-added cobalamin. However, the study did not look at the 
subcellular distribution of cobalamin. Consequently, the Pdu BMCs (wild type, rBMC 
and eBMC) were isolated and their B12 content analysed, from identical cultures as in 
the previous section. The isolated sub-cellular fraction containing BMCs were 
analysed by LC-MS (Figure 5.6). 
 
 
Figure 5.6. Extracted ion chromatogram of purified Pdu microcompartments. Vitamin-B12 (blue) and 
OH-B12 (red) traces of purified BMCs (wild type and rBMC) and eBMCs (A-U). Extra peaks correspond 
to unrelated m/z peaks. 
 
The most abundant cobalamin in purified Pdu BMC (wild type and rBMC) was vitamin-
B12. Traces of OH-B12 were detected in wild type Pdu BMC samples. No traces of Ado-
B12 were detected. In addition, isolated eBMCs (A-U) contained mostly vitamin-B12 
and traces of OH-B12. Ado-B12 was not detected in isolated eBMC samples. Together 
with the data presented in Section 5.7, these results indicate that BMCs have an 
inherent ability to bind cobalamins. Moreover, it suggests that they accumulate 
vitamin-B12. 





5.8. Concentration dependent accumulation of vitamin-B12 with Pdu 
microcompartments 
 
The previous sections provided qualitative evidences for the uptake and 
accumulation of vitamin-B12. In order to quantitate this, vitamin-B12 levels of crude 
lysate samples were compared to samples of purified Pdu microcompartments after 
growth and purification of BMCs at different vitamin-B12 concentrations in the growth 
medium. 
A range of vitamin-B12 concentrations (control, 0.1 µM, 1.0 µM and 10 µM) were fed 
to C. freundii in the presence of 1,2-PD and to E. coli strains producing BtuB with 
rBMC or eBMC (A-U) structures. To quantify any concentration dependent 
accumulation of vitamin-B12 in Pdu microcompartments, crude lysates and purified 
fractions were sampled. Protein levels (Bradford assay, Section 2.8.1) and volume 
were taken into account to calculate a ratio of the vitamin-B12 levels from purified 
BMC fractions to crude lysate samples (Section 2.8.1, Figure 5.8). LC-MS samples of 
crude lysate and purified fraction were prepared and analysed. Vitamin-B12 levels 
were quantified by either UV-Vis absorption maximum at 360 nm or by extracted ion 
chromatogram (Table 5.1). 
Initially the cell pellet of C. freundii was compared visually to the purified pellet of 
wild type Pdu BMCs. Cell pellets of C. freundii and E. coli show cobalamin coloration 
at 1 µM and higher (Figure 5.7). Actually, the wild type BMC pellet shows this 
characteristic coloration even with 0.1 µM vitamin-B12 in the growth medium, which 
is not seen in the bacterial pellet. This visual approach suggests that BMCs are able 
to accumulate vitamin-B12 at a higher rate than the bacterial cell. This observation 
was quantified by comparing the concentration of cobalamin in cell lysates to purified 
BMCs (Table 5.1). 
 





Figure 5.7. Concentration dependent accumulation of cobalamin in BMCs. A visual approach suggests 
the concentration dependent accumulation of cobalamin in wild type Pdu BMCs. Cell pellets of C. 
freundii grown in presence of exogeneous vitamin-B12 show coloration at 1 µM and higher 
concentrations of exogeneous vitamin-B12 in the growth medium. BMC pellets show coloration at 0.1 
µM and higher. Colored pellets are outlined in red. 
 
Wild type Pdu BMCs showed the highest accumulation ratio of 186 (see 
supplementary and Table 5.1), in comparison to rBMC (57) and eBMC (51), when an 
external concentration of 0.1 µM vitamin-B12 was added to the growth medium. 
Thus, at low exogeneous concentrations of vitamin-B12, a relatively high proportion 
of the cobalamin is present in the BMC. As the external concentration of vitamin-B12 
in the growth medium was increased, so the internal distribution of cobalamin within 
the cell dropped, presumably as the BMC becomes saturated with cobalamin. This 










Table 5.1. Accumulation studies of vitamin-B12 in Pdu microcompartments. Average values and 
standard error of mean are given (N=2). 
Accumulation of vitamin-B12 
 Ratios of [vitamin-B12] in BMC to lysate 
0.1 µM 1.0 µM 10 µM 
eBMC (A-U) 51 ± 0.1 14 ± 1.6 4 ± 0.6 
rBMC (A-X) 57 ± 4.3 27 ± 3.1 10 ± 5.9 
wild type 186 ± 47.9 77 ± 1.3 40 ± 2.4 
 
5.9. Fluorescent B12-analogues for fluorescence imaging 
 
In order to follow the partitioning of vitamin-B12 into BMCs, attempts were made to 
generate fluorescent derivatives of cobalamin. Such analogues could potentially be 
used to follow cobalamin acquisition in real time. 
Therefore, fluorescent cobalamin analogues were synthesised, purified and 
characterised for applications in wide field fluorescence microscopy to follow the 
regio-specific localisation of cobalamin. 
 
5.9.1. Synthesis of fluorescent B12-analogues 
 
Two different strategies for cobalamin labelling were attempted (Section 2.5). The 
first strategy involved the replacement of the upper ligand attached to the central 
ĐŽďĂůƚǁŝƚŚĂƐŚŽƌƚ ?ɴ-aminopropyl, provided by Dr. Andrew Lawrence) linker. Texas-
Red-X succinimidyl ester was conjugated onto ƚŚĞ ɴ-aminopropyl upper linker of 
cobalamin (Figure 5.9). Such upper ligand modifications were chosen to preserve the 
recognition for cobalamin transporter proteins. The disadvantage of this modification 
is that the resulting Co-C bound is relatively unstable due to its structural light 




sensitivity. Consequently, the synthesised compound was handled 
under low light conditions. 
 
 
Figure 5.8. Structure of the fluorescent cobalamin analogues. Texas-Red was conjugated to the upper 
ligand (purple). Lower nucleotide loop analogues were raised by conjugating Oregon-Green (green) or 
Bodipy-TR-X (red) to Ethylene Diamine at the Ribose-5`hydroxyl position. 
 
In a second approach ribose-5`-hydroxyl analogues were synthesised by activating 
the hydroxyl group of the ribose at the lower nucleotide loop with 1,1`-
carbonyldiimidazole (CDI) (Figure 5.9; Section 2.5). Addition of Ethylene Diamine 
functionalised the ribose-5`-hydroxyl group of the lower nucleotide loop to allow the 
conjugation of a fluorescent group (Oregon-Green or Bodipy-TR-X) (Figure 5.10). Two 
different cobalamin analogues (Oregon-Green and Bodipy-TR-X-B12) were 
synthesised. In contrast to Texas-Red-B12, the ribose analogues form a non-light 
sensitive covalent bond between vitamin-B12 and the fluorophore (Figure 5.9). After 
synthesis derivatives were analysed by LC-MS (Section 2.8.5). 




The synthesis of the upper ligand analogue, Texas-Red-B12, was a low yielding 
reaction but resulted in sufficient quantities for purification, characterisation and 
imaging. Texas-Red-B12 was identified on the basis of the UV-Vis absorption peaks for 
cobalamin (350 nm) and the fluorophore (587 nm) and a mass to charge ratio (m/z) 
corresponding to the assigned mass of Texas-Red-B12 (Figure 5.8 and Figure 5.9). The 
synthesised compound was not further characterisated, e.g. by NMR. 
 
 
Figure 5.9. LC-MS analysis of the reaction mixtures for cobalamin analogue synthesis. LEFT. LC traces 
including UV chromatogram at 350 or 360 nm (red) for cobalamin specific absorption and absorption 
peak of the fluorophore group absorption (purple or green). The reaction product peak is labelled. 
Other peaks correspond to unreacted cobalamin, fluorophore or breakdown products. RIGHT. UV-Vis 
spectra and mass to charge (m/z) spectra of reaction products peaks. 
 




As with the conjugation reaction to the upper ligand, so the lower loop analogue 
synthesis also resulted in low yielding reactions, which were sufficient for 
purification, characterisation and imaging applications (Section 2.5, Figure 5.9). 
Peaks not corresponding to reaction products of Oregon-Green-B12 and Bodipy-TR-X-
B12 were not characterised further. 
Oregon-Green-B12 was identified on the basis of its UV-Vis absorption peaks for both 
cobalamin (360 nm) and the fluorophore (464 nm), as well as its mass to charge ratio 
(m/z) that corresponds to the predicted mass of Oregon-Green-B12 (Figure 5.8 and 
5.9). 
Bodipy-TR-X-B12 was also identified on the basis of its UV-Vis absorption peaks for 
cobalamin (360 nm) and the fluorophore (580 nm) as well as its mass to charge ratio 
(m/z) corresponding to the predicted mass of Bodipy-TR-X-B12 (Figure 5.8 and 5.9). 
 
5.9.2. Purification of fluorescent B12-analogues 
 
Reaction mixtures of Texas-Red-B12, Oregon-Green-B12 and Bodipy-TR-X-B12 were 
purified from the reaction mixture by preparative LC (Section 2.5). The reaction 
product fraction was collected, dried in vacuo and analysed by LC-MS (Figure 5. 10, 
Section 2.8.5). 





Figure 5.10. LC-MS analysis of purified cobalamin analogues LEFT. LC traces including UV 
chromatogram at 350 or 360 nm (red) for cobalamin specific absorption and absorption peak of the 
fluorophore group (purple or green) absorption. RIGHT. UV-Vis and mass to charge (m/z) spectra for 
each fluorescent cobalamin analogue are shown. 
 
After LC purification, several peaks were still observed for the upper ligand analogue 
Texas-Red-B12. These peaks corresponded to free OH-B12 and fluorophore. This 
demonstrated that Texas-Red-B12 was unstable. 
The lower nucleotide loop analogues purified as single peaks by LC. UV-Vis and mass 
analysis were consistent with the assigned structure and had specific absorption 
maximum for vitamin-B12 at 360 nm and the fluorophore (Figure 5.11). This confirms 
the purity of both Oregon-Green-B12 and Bodipy-TR-X-B12 after purification. Next, the 
bioactivity of these cobalamin analogues was compared. 
 




5.9.3. Fluorescent cobalamin analogues as active cofactors 
 
HPLC-purified cobalamin analogues were tested in a bioassay to determine if they 
still retained cofactor activity for methionine synthase. 
The bioassay is based on the fact that metE knock-out mutants of S. typhimurium 
(AR2680) cells are reliant upon their alternative cobalamin dependent methionine 
synthase, encoded by metH, for the biosynthesis of methionine and the presence of 
exogenous cobalamin (Section 2.6.10). Thus, the addition of a 10 µL drop of 
cobalamin to a bioassay plate stimulates growth, and size of the colony is dependent 
upon the amount of cobalamin within the droplet. Addition of known amounts of 
cobalamin can be used to generate a standard curve, which can then be used to 
estimate the concentration in unknown samples. Similarly, the bioassay can also be 
used to determine the cofactor activity of fluorescent cobalamin analogues of known 
concentrations. The activity of the fluorescent cobalamin analogues was compared 
to OH-B12. Purified cobalamin analogues (2 pmol) and OH-B12 were spotted on the 
cobalamin bioassay plates and cells were grown overnight at 37°C. The colony size of 
OH-B12 was compared to those using fluorescent cobalamin analogues (Figure 5.11). 
 
 
Figure 5.11. Activity of LC purified B12-analogues on a cobalamin bioassay plate. 10 µL (2 pmol) of 
cobalamins were loaded in each case. 
 




All three cobalamin analogues stimulated growth of the bioassay strain. This indicates 
that all three analogues are taken up into the bacterial cell. According to the observed 
growth on the bioassay plate, Texas-Red-B12 had the same activity as OH-B12. This is 
perhaps not surprising because LC purified Texas-Red-B12 was already a mixture of 
OH-B12 and Texas-Red-B12. Section 5.10.2 highlights the instability of the upper 
ligand, resulting in detection of OH-B12 and fluorescent cobalamin in LC-MS analysis. 
In contrast, the lower loop nucleotide analogues Oregon-Green-B12 and Bodipy-TR-X-
B12 produced a greatly reduced growth circle, indicating either hydrolysis of the lower 
loop analogues or a small level of conversion to a bioactive form. Neither of the 
cobalamin analogues was tested for limitations in uptake, assimilation and cofactor 
activity. The intracellular presence of either the complete analogues or derivates was 
not confirmed. 
 
5.10. The spatial co-localisation of synthesised fluorescent cobalamin analogues 
with fluorescently labelled eBMCs 
 
The fluorescent cobalamin analogues were used to investigate the association of 
cobalamin to the BMC ex vivo. This was attempted with labelled eBMC, where 
mCherry (m) or cyano fluorescent protein (CFP) were fused onto PduA. Isolated 
eBMCs (15 µL, CFPA-U and mA-U) were spotted onto glass cover slides and LC purified 
cobalamin fluorophores (Texas-Red-B12, Oregon-Green-B12 and Bodipy-TR-X-B12) 
were added (1 µL, Figure 5.12) and imaged using compatible fluorophore sets in wide 
field fluorescence microscopy (Section 2.9). 
From this approach, wide field fluorescence microscopy was able to provide strong 
evidence for the spatial co-localisation of cobalamin analogues to the eBMC 
structures (Figure 5.12). Firstly, foci of the upper ligand derivative Texas-Red-B12 co-
localised with fluorescently labelled eBMCs (CFPA-U, Panel A). Secondly, the lower 
loop analogue Oregon-Green-B12 co-localised with eBMC (mA-U, Panel B) foci, as did 




the second lower loop derivative Bodipy-TR-X-B12 (CFPA-U, Panel C). However, due 
to resolution limitations, it was not determined if the cobalamin analogues are 









Figure 5.12. Partitioning of fluorescently labelled cobalamin with Pdu microcompartments (CFPA-U 
and mA-U). Panel A shows the effect of Texas-Red-B12 with CFPA-U. Panel B shows the effect of Oregon 





In this chapter the uptake and subcellular distribution of cobalamin with bacterial 
strains producing wild type BMCs, rBMCs and eBMCs was investigated. 
Although cobalamin binding of individual BMC shell proteins was not studied 
systematically, cobalamin is clearly able to associate with intact BMCs, both in vivo 
and in vitro. The BMCs must therefore have a fairly high affinity for cobalamin. Thus, 
the presence of several different shell proteins or the conformation of the intact 
BMC, are suggested to generate an environment that favours cobalamin binding. 
One of the most interesting findings in this chapter was the clear differential 
distribution of cobalamin within the cell. This is consistent with the increased 
sequestration of cobalamin within the BMC lumen. Furthermore, both wild type and 
rBMC were shown to be incapable of converting vitamin-B12 into Ado-B12 
(Section 5.7). These observations were further attested by analysing the cobalamin 
pool of purified BMCs (wild type rBMC and eBMC). In addition to the qualitative 
analyses, a quantitative approach revealed a clear concentration dependent 
accumulation of vitamin-B12 with all tested BMCs (wild type, rBMC and eBMC). The 
lower accumulation in recombinant rBMC and eBMC in E. coli in comparison to wild 
type C. freundii can be explained by the increased number of BMC structures in the 
recombinant systems (rBMC and eBMC, Section 3.3). Although variation of BMC 
building blocks and structural differences between rBMC and eBMCs have been 
described earlier (Chapter 3 and Chapter 4), no differences in vitamin-B12 
accumulation were observed for rBMCs and eBMCs (Table 5.2). 




Moreover, three different fluorescent cobalamin analogues were found to partition 
with labelled Pdu microcompartments in wide field microscopy supporting previous 
biochemical observations. 
E. coli and C. freundii can take up vitamin-B12 into the cell. Together, biochemical 
results point to the fact that vitamin-B12 partitions rapidly into the metabolosomes, 
prior to its conversion into Ado-B12. The BMC is not able to decyanate vitamin-B12 but 
the BMC itself is likely to bind more cobalamin than the cytoplasm of the cell itself. 
This results in the accumulation of vitamin-B12 with the BMC becoming saturated at 
higher concentrations. This explains why the distribution of the cobalamin and the 
BMC appears to drop off as more cobalamin is added to the growth medium. More 
information is required as to how cobalamin binds to the BMC and whether it remains 







Final discussion and conclusions 
  




6.1. BMC formation, a modular, flexible and stable process 
 
BMCs represent a modular and flexible system, which is evidenced by the ability to 
transfer BMC operons to allow the formation of organelles for carbon fixation and 
propanediol utilisation in E. coli (Parsons et al., 2008; Bonacci et al., 2012). 
Furthermore, BMCs can also self-assemble without any internal cargo as evidenced 
by the coordinated production of Pdu BMC shell proteins, which results in the 
formation of intracellular eBMCs (Parsons et al., 2010). 
The formation of such hollow but intact eBMC structures was confirmed and further 
characterised by the biophysical and proteomic approaches described in Chapter 3 
and 4. A proteomic approach involving 2D-PAGE, MALDI TOF-TOF and densitometry 
was used to compare the shell composition of wild type BMCs, rBMCs and eBMCs (A-
U, mA-U, A-T). This revealed subtle but notable variation in shell protein composition 
between the complete BMCs (wild type and rBMC), where PduB` is the major shell 
protein, and the eBMCs, in which a higher level of PduA is incorporated. 
The effect of different shell protein compositions on the shape and physical 
properties of the BMC was further investigated by TEM and AFM, which revealed that 
this variation in shell protein composition does not disrupt BMC assembly. Single 
particle analysis was performed to quantify the irregular and heterogeneous nature 
of the various BMCs in terms of their size. No significant differences between AFM 
and TEM data sets were observed for the complete Pdu BMCs (wild type and rBMC) 
and the eBMC variants (A-U, mA-U and A-T). Thus, AFM allows for the direct 
measurement of BMC particles. With AFM, the wild type and rBMCs were found to 
have a similar size (122-133 nm in average diameter) and to form a defined structure 
independent of the host strain. As with Pdu BMCs, no significant differences were 
observed between the different eBMC variants, which varied in size between 56 to 
77 nm in diameter. Therefore, there is a clear size difference between the complete 
Pdu BMCs (wild type and rBMCs) and the smaller eBMC variants (A-U, mA-U and A-
T). 




The direct measurement of biological samples by AFM allows for the simultaneous 
acquisition of topological features and the determination of nano-mechanical 
properties. Differences in reduced DMT modulus, describing the rigidity and elasticity 
of a biological sample and deformation were estimated for Pdu microcompartments. 
The smaller eBMC variants were found to form more rigid structures than their larger 
Pdu counterparts, which appeared to be more elastic (wild type and rBMC). No major 
differences were observed between wild type and rBMC structures. The different 
nano-mechanical properties of the Pdu BMCs (wild type and rBMCs) in comparison 
to the eBMC variants (A-U, mA-U and A-T) substantiate the idea that Pdu BMCs and 
eBMCs form distinct structures. Furthermore, the eBMCs lack electron density in 
their lumens, in contrast to the more densely packed Pdu microcompartments. 
These observations provide new fundamental insights into the structural variation of 
BMCs and allow a number of conclusions to be drawn. Firstly, the host organism has 
little effect on the complete Pdu BMC in terms of the shell composition, size, nano-
mechanical properties and packing. Secondly, reducing the set of building blocks of 
eBMCs from A-T to A-U does not alter the shell composition, size, nano-mechanical 
parameters or packing of the structure. In addition, the fusion of the fluorescent 
protein mCherry onto PduA has no consequences regarding the shell composition, 
size, nano-mechanical properties and packing of the structure. BMC shell assembly in 
Pdu BMCs (wild type and rBMC) and eBMC variants (A-U, mA-U and A-T) appears to 
have a degree of flexibility, allowing the formation of stable supramolecular 
assemblies within the cell. Internal cargo is not required for BMC assembly. The 
modularity of BMC formation is also seen in carboxysomes. For instance, the pore of 
ƚŚĞɴ-carboxysome shell protein CcmK2 was altered to mimic the pore environment 
of the BMC shell proteins CsoS1 or CcmK4 (Cai et al., 2014), a modification, which did 
ŶŽƚ ĚŝƐƌƵƉƚ ƚŚĞ ɴ-carboxysome assembly in S. elongatus PCC 7942. Similarly, 
ƐǁĂƉƉŝŶŐĐŵ< ?ǁŝƚŚƚŚĞɲ-carboxysomal BMC shell protein CsoS1 did not disrupt 
carboxysome formation.  





6.2. Towards an overall structure of Pdu BMCs 
 
The imaging of the BMCs by AFM and TEM highlighted a general variation in shape 
and size, all of which complicates the determination of an overall structure for the 
Pdu microcompartments. 
This dissertation describes the development of extraction and isolation protocols for 
Pdu microcompartments, methods that are a prerequisite for follow up structural 
analysis by AFM or EM. Furthermore, sample preparations for in-solution AFM, and 
cryo-EM are reported, which can both be employed to provide topographical 
information on the Pdu microcompartments in the longer term (Foster, 2012; Bai et 
al., 2015). However, to determine the overall structure of Pdu microcompartments 
by AFM, in-solution technical challenges such as distortion of the structure during 
deposition and sample drift need to be addressed to take this research forward.  
Alternatively, the overall structural properties of Pdu microcompartments could be 
examined by cryo-EM, as shown for the eBMC A-U in Section 4.7.2. Cryo-electron 
tomography provides a series of 2D images, which can be reconstructed into 3D 
structural models (Bai et al., 2015). Modelled structures of Pdu microcompartment 
structures would then be clustered and characterised. The development of direct 
electron detector for cryo-EM represents a true alternative to the more standard 
structural biology tools such as NMR or X-ray crystallography. In contrast to other 
structural biology tools (crystallography and NMR), cryo-EM requires less sample as 
little as 0.1 mg may be enough and sample purity is less crucial for the acquisition of 
cryo-EM data. These developments can be seen in the increasing number of reports 
of structural cryo-EM data with resolutions higher than 5 Å between 2013 and 2015 
(Bai et al., 2015). Therefore, cryo-EM and AFM represent powerful tools to solve the 
overall structure of irregular Pdu microcompartments. Such a structural 
characterisation will help us to understand the functional role of the organelle in 




more detail, by providing essential information on the orientation and positioning of 
shell proteins within the overall structure. 
 
6.3. An additional functional role of the Pdu BMC  
 
The central pores in the Pdu shell proteins are thought to be involved in the transport 
of a wide variety of molecules such as substrates, metabolites and cofactors (Frank 
et al., 2013; Chowdhury et al., 2014). The shell of the BMC forms a semi-permeable 
protein membrane, whereby the central pores offer selective movement into or out 
of the BMC (Frank et al., 2013; Deery et al., 2014; Chessher et al., 2015). 
In this study, an in vitro approach revealed that when BMCs (wild type, rBMC and 
eBMC (A-U)) were incubated with different cobalamins (Ado-B12, Me-B12, OH-B12 and 
vitamin-B12), that the cobalamins localised to the organelles during purification. In 
vivo, a similar observation was made. When bacterial strains were grown with 
exogenous cobalamin, cobalamin was found to accumulate with the BMC. This was 
derived from the development of methods to quantitatively estimate the distribution 
of cobalamin within the cell. However, it was also shown that the accumulation of B12 
in the BMC followed a saturation dependent uptake process. This uptake was found 
not only with the complete Pdu BMC but also with the eBMC (A-U). Therefore, the 
association of cobalamin with the BMC is independent of any incorporated Ado-B12 
dependent enzymes (PduCDE) and reactivation factors (PduGH, PduO and PduS). To 
visualise the association of cobalamin with the BMC, various fluorescent B12-
analogues were generated, purified and characterised. Incubation of the fluorescent 
B12 molecules with purified eBMCs resulted in their co-localisation as determined by 
fluorescent microscopy. Surprisingly though, the BMCs do not house the ability to 
activate vitamin-B12. 
In terms of metabolic engineering, the ability to selectively take up cofactors such as 
cobalamin is a desired feature for the sequestration of biological processes and 








6.4. BMCs in the context of metabolic engineering 
 
We are in the era of synthetic biology, whereby our ability to perform large scale 
sequencing, coupled with the development of relatively cheap DNA synthesis, means 
that we can protein engineer and redesign major biological processes for useful 
purposes. 
Major achievements in the field are exemplified by the recombinant biosynthesis of 
complex metabolic products such as cobalamin in E. coli, artemisinic acid in 
S. cerevisiae and opium in Saccharomyces cerevisiae (Ro et al., 2006; Deery et al., 
2012; Fossati et al., 2015). 
However, metabolic engineering remains challenging (Chessher et al., 2015). 
Transplanted metabolic pathways have to compete with other cellular processes for 
substrates and cofactors. Furthermore, intermediates can be toxic or diverted by 
competing processes. This can reduce the efficiency of the metabolic pathway, lead 
to the accumulation of intermediates, or cause toxicity issues. Consequently, 
bioengineers aim to reduce such detrimental effects by increasing the local 
concentration of pathway enzymes or by sequestering metabolic pathways. In this 
respect, several strategies have been reported in recent years including the use of 
cellular scaffolds to link consecutive metabolic enzymes via DNA, RNA or other 
proteins in order to increase the local concentration of consecutive enzymes (Frank 
et al., 2013; Giessen; Silver, 2015; Siu et al., 2015). The scaffolding of metabolic 
enzymes can increase the throughput of a metabolic pathway without sequestering 
the pathway from the cytoplasm (Chessher et al., 2015; Siu et al., 2015). 




Alternatively, pathways can be sequestered to viral capsids or to BMCs in order to 
segregate metabolic pathways from the cytoplasm (Grasso; Santi, 2010). From a 
biological perspective, BMC based systems appear to be superior to other systems. 
For instance, scaffolding mechanisms are not spatially segregated from cellular 
processes and viral capsids evolved to maintain mainly genomic information, and 
therefore, are not designed for metabolism. In contrast, bacterial organelles evolved 
to optimise and sequester metabolic pathways. This suggests that BMC based 
systems offer an ideal platform for metabolic engineering, as shown in Figure 6.1. 
To apply BMC based systems, it is crucial to understand the structure and function of 
the system. Thus, fundamental insights into the BMC shell composition, the 
biophysical properties of the compartment, as well as the knowledge of cofactor 
uptake and accumulation mechanisms will all assist the redesign of BMCs for new 
biotechnological applications. 
 
Figure 6.1. Advantages of BMC based systems in the context of synthetic biology (Deery et al., 2014). 






This study on wild type, rBMC and eBMC system provides fundamental insights into 
the BMC shell composition and its associated biophysical characteristics. The ability 
of BMCs to increase the local concentration of cobalamin has been uncovered. This 
was achieved by improving methods for BMC isolation, generating samples that show 
the intact nature of the isolated BMCs and resulting in the detailed proteomic and 
biophysical comparison of wild type and rBMCs to eBMC variants. Interestingly, Pdu 
BMCs (wild type and recombinant) showed no obvious proteomic differences, which 
is consistent with the formation of similar sized structures that have near identical 
nano-mechanical properties. It was shown that empty Pdu BMCs (eBMCs) are 
different from wild type and rBMCs in shell protein composition (shift to PduA), 
smaller size and more rigid assemblies (see Figure 6.2). Furthermore, eBMCs were 
shown to be hollow in contrast to their propanediol utilising counterparts. The 
research described in this thesis demonstrates that Pdu BMCs are able to accumulate 
B12 both in vitro and in vivo. The synthesis of fluorescently labelled B12-analogues has 
allowed the development of a novel visualisation of the co-localisation of cobalamin 
to fluorescently labelled eBMC shells ex vivo. 
 














7.1. Tandem mass spectrometry 
 
Table 7.1. In-detail analysis of single shell protein spots from 2D-PAGE. NCBI accession number, 
number of peptide matches, probability based Mowse score and sequence coverage [%] are given for 
each eBMC construct (A-U, mA-U and A-T) and BMC (rBMC and wild-type). 
A-U Mascot search result 












PduA gi446152585 4(0) 141 54 
PduB gi489930809 4(1) 211 22 
PduB` gi507082779 5(1) 131 17 
PduJ gi668711810 3(2) 163 53 
PduK gi489930823 1(0) 46 14 
PduN gi507086135 1(1) 81 25 
PduU gi489940949 3(0) 94 32 
mA-U Mascot search result 
PduA gi446152585 2(1) 101 25 
mCherryPduA gi55420613/ 4(2)/1(1) 227/65 23/13 
gi446152585 
PduB gi489930809 6(5) 582 45 
PduB` gi489930809 4(4) 395 20 
PduJ gi446980496 3 (2) 259 53 
PduK gi489930823 2(1) 112 20 
PduN gi507086135 1(1) 112 25 
PduU gi489940949 2(2) 265 25 





PduA gi446152585 3(0) 99 41 
PduB gi489930809 5(2) 274 32 
PduB` gi489930809 5(2) 256 32 
PduJ gi446980496 4(1) 216 78 
PduK gi489930823 1(1) 72 14 
PduN gi507086135 2(0) 75 36 
PduU gi489930848 2(2) 160 27 
PduT gi489940949 2(1) 95 18 
 
rBMC construct: A-X Mascot search result 
Identity 
assigned 








PduA gi446152585 3(1) 141 49 
PduB gi489930809 6(4) 427 40 
PduB` gi489930809 5(4) 424 28 
PduJ gi446980496 4(2) 267 59 
PduK gi489936823 1(1) 76 14 
PduN gi507086135 1(1) 88 25 
PduT gi489940949 4(0) 90 18 
PduU gi489940949 2(1) 133 27 
wild type Mascot search result 
PduA gi446152585 4(2) 211 46 
PduB gi489930809 4(2) 236 24 
PduB` gi489930809 4(2) 240 20 
PduJ gi446980496 3(2) 133 35 





PduN gi507086135 1(1) 114 25 
PduT gi489940949 1(1) 65 7 
PduU gi489940949 2(0) 102 16 
 
7.2. Ratios B12 calculation 
 
Table 7.2. Accumulation of vitamin-B12 in BMCs (eBMC, rBMC and wild type). 
Accumulation of vitamin-B12 









0.1 µM 1.0 µM 10 
0 µM 






51 ± 0.1 14 ± 1.6 4 ± 0.6 
1. BMC 





0.56 2. BMC 






57 ± 4.3 27 ± 3.1 10 ± 5.9 
1. BMC 





0.155 2. BMC 






186 ± 47.9 77 ± 1.3 40 ± 2.4 
1. BMC 
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